| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone modifying activity | 2.50e-07 | 229 | 101 | 10 | GO:0140993 | |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 1.15e-05 | 28 | 101 | 4 | GO:0141052 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 1.75e-05 | 31 | 101 | 4 | GO:0032452 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 1.99e-05 | 32 | 101 | 4 | GO:0140457 | |
| GeneOntologyMolecularFunction | demethylase activity | 7.17e-05 | 44 | 101 | 4 | GO:0032451 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 8.80e-05 | 143 | 101 | 6 | GO:0017124 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | ABL1 TCF20 NACA SIN3A BCL11A ARID1A NCOR2 SETD5 KAT6B HCFC1 KDM1A | 1.28e-04 | 562 | 101 | 11 | GO:0003712 |
| GeneOntologyMolecularFunction | histone H3K36 trimethyltransferase activity | 2.51e-04 | 5 | 101 | 2 | GO:0140955 | |
| GeneOntologyMolecularFunction | histone H3K27me2/H3K27me3 demethylase activity | 2.51e-04 | 5 | 101 | 2 | GO:0071558 | |
| GeneOntologyMolecularFunction | 2-oxoglutarate-dependent dioxygenase activity | 3.29e-04 | 65 | 101 | 4 | GO:0016706 | |
| GeneOntologyMolecularFunction | chromatin binding | SIN3A ARID1A GATAD2B PHC1 NCOR2 CTCF DPPA4 KAT6B KDM6A UTY HCFC1 KDM1A | 3.53e-04 | 739 | 101 | 12 | GO:0003682 |
| GeneOntologyMolecularFunction | histone H3K9me2/H3K9me3 demethylase activity | 3.75e-04 | 6 | 101 | 2 | GO:0140684 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 8.81e-04 | 303 | 101 | 7 | GO:0003713 | |
| GeneOntologyMolecularFunction | histone H3K14 acetyltransferase activity | 8.91e-04 | 9 | 101 | 2 | GO:0036408 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | DLG5 CNKSR1 ABL1 TCF20 NACA SIN3A BCL11A ARID1A ADAM10 TRDN NCOR2 CTCF SETD5 KAT6B HCFC1 KDM1A | 1.24e-03 | 1356 | 101 | 16 | GO:0060090 |
| GeneOntologyMolecularFunction | histone H3K36 demethylase activity | 1.35e-03 | 11 | 101 | 2 | GO:0051864 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 1.43e-03 | 44 | 101 | 3 | GO:0140938 | |
| GeneOntologyMolecularFunction | dioxygenase activity | 1.55e-03 | 98 | 101 | 4 | GO:0051213 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 1.60e-03 | 167 | 101 | 5 | GO:0031490 | |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 1.91e-03 | 13 | 101 | 2 | GO:0046975 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | DLG5 CNKSR1 ABL1 TCF20 NACA SIN3A BCL11A ARID1A TRDN NCOR2 SETD5 KAT6B HCFC1 KDM1A | 2.08e-03 | 1160 | 101 | 14 | GO:0030674 |
| GeneOntologyMolecularFunction | histone H3K9 demethylase activity | 2.22e-03 | 14 | 101 | 2 | GO:0032454 | |
| GeneOntologyMolecularFunction | SH2 domain binding | 2.32e-03 | 52 | 101 | 3 | GO:0042169 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 2.55e-03 | 15 | 101 | 2 | GO:0010484 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | BRPF3 KMT2B SIN3A HUWE1 ARID1A GATAD2B PHC1 SETD2 ZNF827 CTCF SETD5 KAT6B KDM6A UTY HCFC1 KDM1A KDM4B | 6.93e-08 | 741 | 98 | 17 | GO:0006338 |
| GeneOntologyBiologicalProcess | chromatin organization | BRPF3 KMT2B SIN3A HUWE1 ARID1A GATAD2B PHC1 SETD2 ZNF827 CTCF SETD5 KAT6B KDM6A UTY HCFC1 KDM1A KDM4B | 1.00e-06 | 896 | 98 | 17 | GO:0006325 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | BRPF3 KMT2B SIN3A HUWE1 ARID1A GATAD2B PHC1 SETD2 ZNF827 CTCF SETD5 KAT6B KDM6A UTY HCFC1 KDM1A KDM4B | 4.36e-06 | 999 | 98 | 17 | GO:0071824 |
| GeneOntologyBiologicalProcess | cell morphogenesis | ABL1 RAPH1 SPRR1A SPRR1B CDHR1 FAT3 CD2AP SIN3A BCL11A PEAK3 ADAM8 ADAM10 PRAG1 OPHN1 MAP1S SH3D19 SLITRK5 KDM1A | 1.17e-05 | 1194 | 98 | 18 | GO:0000902 |
| GeneOntologyBiologicalProcess | dendrite development | 3.13e-05 | 335 | 98 | 9 | GO:0016358 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | DOK1 CNKSR1 ABL1 CD2AP RAPGEF1 PRAG1 OPHN1 DOCK5 RHOBTB1 PHACTR4 SOS2 | 4.96e-05 | 538 | 98 | 11 | GO:0007264 |
| GeneOntologyBiologicalProcess | heart development | ABL1 NACA FGFRL1 ARID1A NCOR2 SETD2 SH3PXD2B XIRP2 CTCF MAPK11 CPLANE1 KDM6A UTY | 5.99e-05 | 757 | 98 | 13 | GO:0007507 |
| GeneOntologyBiologicalProcess | neuron projection development | DLG5 SETX ABL1 RAPH1 FAT3 CD2AP RAPGEF1 SIN3A BCL11A ADAM10 PRAG1 OPHN1 ASAP1 MAP1S SLITRK5 CAMSAP2 KDM1A | 1.08e-04 | 1285 | 98 | 17 | GO:0031175 |
| GeneOntologyBiologicalProcess | Rho protein signal transduction | 1.33e-04 | 164 | 98 | 6 | GO:0007266 | |
| GeneOntologyBiologicalProcess | circulatory system development | ABL1 NACA RAPGEF1 FGFRL1 ARID1A ADAM8 ADAM10 CEMIP2 NCOR2 SETD2 SH3PXD2B XIRP2 CTCF SLITRK5 MAPK11 CPLANE1 KDM6A UTY | 1.37e-04 | 1442 | 98 | 18 | GO:0072359 |
| GeneOntologyBiologicalProcess | neuron development | DLG5 SETX ABL1 RAPH1 CDHR1 FAT3 CD2AP RAPGEF1 SIN3A BCL11A ADAM10 PRAG1 OPHN1 ASAP1 MAP1S SLITRK5 CAMSAP2 KDM1A | 1.65e-04 | 1463 | 98 | 18 | GO:0048666 |
| GeneOntologyBiologicalProcess | neural tube closure | 2.04e-04 | 113 | 98 | 5 | GO:0001843 | |
| GeneOntologyBiologicalProcess | tube closure | 2.13e-04 | 114 | 98 | 5 | GO:0060606 | |
| GeneOntologyBiologicalProcess | primary neural tube formation | 2.70e-04 | 120 | 98 | 5 | GO:0014020 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 3.15e-04 | 124 | 98 | 5 | GO:0007229 | |
| GeneOntologyCellularComponent | podosome | 1.48e-06 | 41 | 100 | 5 | GO:0002102 | |
| GeneOntologyCellularComponent | actin cytoskeleton | DENND2A AMPH CTTNBP2 ABL1 CD2AP PEAK3 ADAM8 OPHN1 ASAP1 DOCK5 SH3PXD2B XIRP2 FYB1 | 3.66e-06 | 576 | 100 | 13 | GO:0015629 |
| GeneOntologyCellularComponent | histone methyltransferase complex | 4.62e-04 | 75 | 100 | 4 | GO:0035097 | |
| GeneOntologyCellularComponent | MOZ/MORF histone acetyltransferase complex | 4.68e-04 | 7 | 100 | 2 | GO:0070776 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | CYLC1 DOK1 ABL1 SPRR1A GGN SPRR1B PCLO CD2AP RAPGEF1 ADAM10 MAP1S SYNJ1 CKAP4 | 5.06e-04 | 934 | 100 | 13 | GO:0048471 |
| GeneOntologyCellularComponent | H3 histone acetyltransferase complex | 6.23e-04 | 8 | 100 | 2 | GO:0070775 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 7.42e-04 | 85 | 100 | 4 | GO:0000118 | |
| GeneOntologyCellularComponent | chromosomal region | 9.38e-04 | 421 | 100 | 8 | GO:0098687 | |
| GeneOntologyCellularComponent | distal axon | 1.16e-03 | 435 | 100 | 8 | GO:0150034 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 1.45e-03 | 12 | 100 | 2 | GO:0044666 | |
| GeneOntologyCellularComponent | methyltransferase complex | 1.81e-03 | 108 | 100 | 4 | GO:0034708 | |
| HumanPheno | Thin upper lip vermilion | TCF20 SIN3A BCL11A HUWE1 ARID1A CHAMP1 CCNK GATAD2B OPHN1 PHC1 SH3PXD2B CTCF SETD5 KAT6B KDM6A UNC80 KDM1A KDM4B | 2.33e-12 | 339 | 37 | 18 | HP:0000219 |
| HumanPheno | Thin lips | TCF20 SIN3A BCL11A HUWE1 ARID1A CHAMP1 CCNK GATAD2B OPHN1 PHC1 SH3PXD2B CTCF SETD5 KAT6B KDM6A UNC80 KDM1A KDM4B | 2.33e-12 | 339 | 37 | 18 | HP:0000213 |
| HumanPheno | Thin vermilion border | ABL1 TCF20 SIN3A BCL11A HUWE1 ARID1A CHAMP1 CCNK GATAD2B OPHN1 PHC1 SH3PXD2B CTCF SETD5 KAT6B KDM6A UNC80 KDM1A KDM4B | 1.31e-11 | 433 | 37 | 19 | HP:0000233 |
| HumanPheno | Abnormal nasal tip morphology | KMT2B TCF20 SIN3A BCL11A HUWE1 ARID1A CCNK GATAD2B SETD2 SH3PXD2B CTCF SETD5 CPLANE1 KAT6B KDM6A UNC80 KDM1A KDM4B | 2.14e-11 | 386 | 37 | 18 | HP:0000436 |
| HumanPheno | Abnormality of upper lip vermillion | TCF20 SIN3A BCL11A HUWE1 ARID1A CHAMP1 CCNK GATAD2B OPHN1 PHC1 SH3PXD2B CTCF SETD5 KAT6B KDM6A UNC80 KDM1A KDM4B | 4.67e-10 | 464 | 37 | 18 | HP:0011339 |
| HumanPheno | Abnormal upper lip morphology | ABL1 TCF20 PCLO FGFRL1 SIN3A BCL11A HUWE1 ARID1A CHAMP1 CCNK GATAD2B OPHN1 PHC1 SH3PXD2B CTCF SETD5 CPLANE1 KAT6B KDM6A UNC80 KDM1A KDM4B | 6.99e-08 | 980 | 37 | 22 | HP:0000177 |
| HumanPheno | Abnormality of calvarial morphology | ABL1 KMT2B TCF20 PCLO FGFRL1 SIN3A HUWE1 CHAMP1 GATAD2B OPHN1 SETD2 SH3PXD2B SYNJ1 CTCF SETD5 CPLANE1 KAT6B KDM6A HCFC1 UNC80 KDM1A KDM4B SOS2 | 1.88e-07 | 1134 | 37 | 23 | HP:0002648 |
| HumanPheno | Abnormal lip morphology | DLG5 ABL1 TCF20 PCLO FGFRL1 SIN3A BCL11A HUWE1 ARID1A CHAMP1 CCNK GATAD2B OPHN1 PHC1 SH3PXD2B CTCF SETD5 CPLANE1 KAT6B KDM6A UNC80 KDM1A KDM4B SOS2 | 2.19e-07 | 1249 | 37 | 24 | HP:0000159 |
| HumanPheno | Abnormality of the palpebral fissures | ABL1 PCLO SIN3A BCL11A HUWE1 CHAMP1 CCNK GATAD2B PHC1 SETD2 SH3PXD2B SYNJ1 CTCF SETD5 KAT6B KDM6A UNC80 KDM1A KDM4B SOS2 | 3.76e-07 | 880 | 37 | 20 | HP:0008050 |
| HumanPheno | Abnormal eyelid morphology | ABL1 KMT2B TCF20 PCLO FGFRL1 SIN3A BCL11A HUWE1 ARID1A CHAMP1 CCNK GATAD2B PHC1 SETD2 SH3PXD2B SYNJ1 CTCF SETD5 CPLANE1 KAT6B KDM6A UNC80 KDM1A KDM4B SOS2 | 4.54e-07 | 1408 | 37 | 25 | HP:0000492 |
| HumanPheno | Abnormality of the hairline | FGFRL1 SIN3A HUWE1 ARID1A CCNK SETD2 CTCF SETD5 KDM6A KDM1A KDM4B SOS2 | 5.50e-07 | 294 | 37 | 12 | HP:0009553 |
| HumanPheno | Abnormality of the forehead | ABL1 KMT2B TCF20 FGFRL1 SIN3A HUWE1 ARID1A CCNK GATAD2B OPHN1 PHC1 SETD2 SH3PXD2B SYNJ1 CTCF SETD5 CPLANE1 KAT6B KDM6A UNC80 KDM1A KDM4B SOS2 | 6.36e-07 | 1208 | 37 | 23 | HP:0000290 |
| HumanPheno | Frontal bossing | ABL1 KMT2B TCF20 FGFRL1 SIN3A HUWE1 GATAD2B OPHN1 SETD2 SH3PXD2B SYNJ1 CTCF SETD5 CPLANE1 KDM6A UNC80 KDM1A SOS2 | 7.59e-07 | 738 | 37 | 18 | HP:0002007 |
| HumanPheno | Slanting of the palpebral fissure | ABL1 SIN3A BCL11A HUWE1 CHAMP1 GATAD2B PHC1 SETD2 SH3PXD2B SYNJ1 CTCF SETD5 KAT6B KDM6A UNC80 KDM1A KDM4B SOS2 | 7.74e-07 | 739 | 37 | 18 | HP:0200006 |
| HumanPheno | Abnormal shape of the frontal region | ABL1 KMT2B TCF20 FGFRL1 SIN3A HUWE1 GATAD2B OPHN1 SETD2 SH3PXD2B SYNJ1 CTCF SETD5 CPLANE1 KDM6A UNC80 KDM1A SOS2 | 8.07e-07 | 741 | 37 | 18 | HP:0011218 |
| HumanPheno | Abnormal frontal bone morphology | ABL1 KMT2B TCF20 FGFRL1 SIN3A HUWE1 GATAD2B OPHN1 SETD2 SH3PXD2B SYNJ1 CTCF SETD5 CPLANE1 KDM6A UNC80 KDM1A SOS2 | 8.24e-07 | 742 | 37 | 18 | HP:0430000 |
| HumanPheno | High forehead | TCF20 FGFRL1 SIN3A HUWE1 SETD2 SH3PXD2B SYNJ1 CTCF SETD5 KDM6A UNC80 SOS2 | 8.47e-07 | 306 | 37 | 12 | HP:0000348 |
| HumanPheno | Short philtrum | FGFRL1 SIN3A HUWE1 ARID1A CHAMP1 GATAD2B OPHN1 SH3PXD2B CTCF UNC80 KDM4B | 9.88e-07 | 253 | 37 | 11 | HP:0000322 |
| HumanPheno | Abnormal calvaria morphology | ABL1 KMT2B TCF20 PCLO FGFRL1 SIN3A HUWE1 CHAMP1 GATAD2B OPHN1 SETD2 SH3PXD2B SYNJ1 CTCF SETD5 CPLANE1 KAT6B KDM6A HCFC1 UNC80 KDM1A KDM4B SOS2 | 1.30e-06 | 1254 | 37 | 23 | HP:0002683 |
| HumanPheno | Broad nasal tip | 1.32e-06 | 159 | 37 | 9 | HP:0000455 | |
| HumanPheno | Congenital abnormal hair pattern | FGFRL1 SIN3A HUWE1 ARID1A CCNK SETD2 CTCF SETD5 KDM6A KDM1A KDM4B SOS2 | 1.72e-06 | 327 | 37 | 12 | HP:0011361 |
| HumanPheno | Anteverted nares | SIN3A BCL11A HUWE1 ARID1A CCNK GATAD2B SETD2 SH3PXD2B CTCF SETD5 CPLANE1 KDM6A UNC80 KDM1A KDM4B | 3.13e-06 | 559 | 37 | 15 | HP:0000463 |
| HumanPheno | Upturned nose | SIN3A BCL11A HUWE1 ARID1A CCNK GATAD2B SETD2 SH3PXD2B CTCF SETD5 CPLANE1 KDM6A UNC80 KDM1A KDM4B | 3.13e-06 | 559 | 37 | 15 | HP:0000427 |
| HumanPheno | Abnormality of the philtrum | ABL1 PCLO FGFRL1 SIN3A HUWE1 ARID1A CHAMP1 CCNK GATAD2B OPHN1 SH3PXD2B CTCF SETD5 KAT6B KDM6A UNC80 KDM4B | 3.33e-06 | 726 | 37 | 17 | HP:0000288 |
| HumanPheno | Abnormal external nose morphology | KMT2B TCF20 FGFRL1 SIN3A BCL11A HUWE1 ARID1A CCNK GATAD2B SETD2 SH3PXD2B CTCF SETD5 CPLANE1 KAT6B KDM6A UNC80 KDM1A KDM4B | 3.89e-06 | 916 | 37 | 19 | HP:0010938 |
| HumanPheno | Abnormality of mouth shape | ABL1 TCF20 PCLO FGFRL1 SIN3A CHAMP1 CTCF SETD5 UNC80 KDM1A KDM4B | 4.35e-06 | 294 | 37 | 11 | HP:0011338 |
| HumanPheno | Clinodactyly | ABL1 KMT2B TCF20 SIN3A HUWE1 ARID1A CCNK SH3PXD2B CTCF CPLANE1 KAT6B KDM6A KDM1A KDM4B SOS2 | 4.38e-06 | 574 | 37 | 15 | HP:0030084 |
| HumanPheno | Abnormal nostril morphology | SIN3A BCL11A HUWE1 ARID1A CCNK GATAD2B SETD2 SH3PXD2B CTCF SETD5 CPLANE1 KDM6A UNC80 KDM1A KDM4B | 4.47e-06 | 575 | 37 | 15 | HP:0005288 |
| HumanPheno | Abnormal size of the palpebral fissures | PCLO SIN3A HUWE1 CCNK GATAD2B SETD2 CTCF SETD5 KAT6B KDM6A KDM4B | 4.97e-06 | 298 | 37 | 11 | HP:0200007 |
| HumanPheno | Abnormality of the scalp hair | FGFRL1 SIN3A HUWE1 ARID1A CCNK SETD2 CTCF SETD5 KAT6B KDM6A KDM1A KDM4B SOS2 | 5.40e-06 | 433 | 37 | 13 | HP:0100037 |
| HumanPheno | Wide nasal bridge | FGFRL1 SIN3A CCNK GATAD2B OPHN1 SETD2 SH3PXD2B CTCF SETD5 KAT6B KDM6A UNC80 KDM1A KDM4B | 5.64e-06 | 508 | 37 | 14 | HP:0000431 |
| HumanPheno | Abnormal 5th finger morphology | ABL1 KMT2B TCF20 SIN3A ARID1A CCNK SH3PXD2B CTCF CPLANE1 KAT6B KDM6A KDM1A KDM4B SOS2 | 5.77e-06 | 509 | 37 | 14 | HP:0004207 |
| HumanPheno | Restricted or repetitive behaviors or interests | TCF20 FGFRL1 SIN3A BCL11A HUWE1 CHAMP1 CCNK GATAD2B OPHN1 CTCF SETD5 KDM4B | 5.98e-06 | 368 | 37 | 12 | HP:0031432 |
| HumanPheno | Perseverative thought | TCF20 FGFRL1 SIN3A BCL11A HUWE1 CHAMP1 CCNK GATAD2B OPHN1 CTCF SETD5 KDM4B | 7.69e-06 | 377 | 37 | 12 | HP:0030223 |
| HumanPheno | Radial deviation of finger | ABL1 KMT2B TCF20 SIN3A CCNK SH3PXD2B CTCF CPLANE1 KAT6B KDM6A KDM1A KDM4B SOS2 | 7.88e-06 | 448 | 37 | 13 | HP:0009466 |
| HumanPheno | Abnormal scalp morphology | FGFRL1 SIN3A HUWE1 ARID1A CCNK SETD2 CTCF SETD5 KAT6B KDM6A KDM1A KDM4B SOS2 | 8.28e-06 | 450 | 37 | 13 | HP:0001965 |
| HumanPheno | Finger clinodactyly | ABL1 KMT2B TCF20 SIN3A CCNK SH3PXD2B CTCF CPLANE1 KAT6B KDM6A KDM1A KDM4B SOS2 | 8.70e-06 | 452 | 37 | 13 | HP:0040019 |
| HumanPheno | Radial deviation of the hand or of fingers of the hand | ABL1 KMT2B TCF20 SIN3A CCNK SH3PXD2B CTCF CPLANE1 KAT6B KDM6A KDM1A KDM4B SOS2 | 9.58e-06 | 456 | 37 | 13 | HP:0009485 |
| HumanPheno | Disordered formal thought process | TCF20 FGFRL1 SIN3A BCL11A HUWE1 CHAMP1 CCNK GATAD2B OPHN1 CTCF SETD5 KDM4B | 9.81e-06 | 386 | 37 | 12 | HP:0025769 |
| HumanPheno | Abnormal thought pattern | TCF20 FGFRL1 SIN3A BCL11A HUWE1 CHAMP1 CCNK GATAD2B OPHN1 CTCF SETD5 KDM4B | 1.57e-05 | 404 | 37 | 12 | HP:5200269 |
| HumanPheno | Abnormal morphology of the nasal alae | SIN3A BCL11A HUWE1 ARID1A CCNK GATAD2B SETD2 SH3PXD2B CTCF SETD5 CPLANE1 KDM6A UNC80 KDM1A KDM4B | 1.66e-05 | 639 | 37 | 15 | HP:0000429 |
| HumanPheno | Abnormal nasal bridge morphology | TCF20 PCLO FGFRL1 SIN3A HUWE1 ARID1A CCNK GATAD2B OPHN1 SETD2 SH3PXD2B CTCF SETD5 CPLANE1 KAT6B KDM6A UNC80 KDM1A KDM4B | 2.29e-05 | 1029 | 37 | 19 | HP:0000422 |
| HumanPheno | Clinodactyly of the 5th finger | ABL1 KMT2B TCF20 SIN3A CCNK SH3PXD2B CTCF KAT6B KDM6A KDM1A KDM4B SOS2 | 2.32e-05 | 420 | 37 | 12 | HP:0004209 |
| HumanPheno | Clinodactyly of hands | ABL1 KMT2B TCF20 SIN3A CCNK SH3PXD2B CTCF KAT6B KDM6A KDM1A KDM4B SOS2 | 2.38e-05 | 421 | 37 | 12 | HP:0001157 |
| HumanPheno | Deviation of the 5th finger | ABL1 KMT2B TCF20 SIN3A CCNK SH3PXD2B CTCF KAT6B KDM6A KDM1A KDM4B SOS2 | 2.38e-05 | 421 | 37 | 12 | HP:0009179 |
| HumanPheno | Downslanted palpebral fissures | SIN3A BCL11A HUWE1 SETD2 SH3PXD2B SYNJ1 CTCF SETD5 KAT6B KDM6A UNC80 KDM1A SOS2 | 2.45e-05 | 497 | 37 | 13 | HP:0000494 |
| HumanPheno | Abnormal hand morphology | DLG5 ABL1 KMT2B TCF20 FGFRL1 SIN3A HUWE1 ARID1A CCNK SETD2 SH3PXD2B CTCF CPLANE1 KAT6B KDM6A UNC80 KDM1A KDM4B SOS2 | 4.82e-05 | 1082 | 37 | 19 | HP:0005922 |
| HumanPheno | Deviation of finger | ABL1 KMT2B TCF20 SIN3A CCNK SH3PXD2B CTCF CPLANE1 KAT6B KDM6A KDM1A KDM4B SOS2 | 5.61e-05 | 537 | 37 | 13 | HP:0004097 |
| HumanPheno | Brachycephaly | 5.83e-05 | 253 | 37 | 9 | HP:0000248 | |
| HumanPheno | Long face | 7.00e-05 | 259 | 37 | 9 | HP:0000276 | |
| HumanPheno | Phimosis | 7.42e-05 | 12 | 37 | 3 | HP:0001741 | |
| HumanPheno | Deeply set eye | 8.62e-05 | 266 | 37 | 9 | HP:0000490 | |
| HumanPheno | Deviation of the hand or of fingers of the hand | ABL1 KMT2B TCF20 SIN3A CCNK SH3PXD2B CTCF CPLANE1 KAT6B KDM6A KDM1A KDM4B SOS2 | 9.39e-05 | 564 | 37 | 13 | HP:0009484 |
| HumanPheno | Cupped ear | 1.23e-04 | 69 | 37 | 5 | HP:0000378 | |
| HumanPheno | Motor stereotypy | 1.28e-04 | 280 | 37 | 9 | HP:0000733 | |
| HumanPheno | Large face | 1.39e-04 | 283 | 37 | 9 | HP:0100729 | |
| HumanPheno | Long palpebral fissure | 1.41e-04 | 71 | 37 | 5 | HP:0000637 | |
| HumanPheno | Autistic behavior | KMT2B TCF20 SIN3A BCL11A ARID1A CCNK GATAD2B OPHN1 SETD2 SYNJ1 CTCF SETD5 KDM6A KDM4B | 1.52e-04 | 678 | 37 | 14 | HP:0000729 |
| HumanPheno | Abnormality of the jaws | ABL1 KMT2B FGFRL1 SIN3A BCL11A HUWE1 CCNK GATAD2B OPHN1 SETD2 SH3PXD2B CTCF SETD5 CPLANE1 KAT6B KDM6A UNC80 KDM4B SOS2 | 1.58e-04 | 1175 | 37 | 19 | HP:0000209 |
| HumanPheno | Thin corpus callosum | PCLO FGFRL1 SIN3A HUWE1 ARID1A PHC1 SETD2 SH3PXD2B SYNJ1 CTCF CPLANE1 KAT6B KDM6A UNC80 KDM1A KDM4B | 1.60e-04 | 868 | 37 | 16 | HP:0033725 |
| HumanPheno | Abnormal jaw morphology | ABL1 KMT2B FGFRL1 SIN3A BCL11A HUWE1 CCNK GATAD2B OPHN1 SETD2 SH3PXD2B CTCF SETD5 CPLANE1 KAT6B KDM6A UNC80 KDM4B SOS2 | 1.60e-04 | 1176 | 37 | 19 | HP:0030791 |
| HumanPheno | Abnormally increased volition | KMT2B TCF20 SIN3A BCL11A HUWE1 ARID1A CHAMP1 GATAD2B OPHN1 SETD2 SYNJ1 CTCF SETD5 UNC80 KDM1A KDM4B | 1.63e-04 | 869 | 37 | 16 | HP:5200263 |
| HumanPheno | Language impairment | KMT2B TCF20 SIN3A HUWE1 ARID1A CHAMP1 CCNK GATAD2B OPHN1 SETD2 KCNQ5 SYNJ1 CTCF SETD5 KAT6B KDM6A UNC80 KDM1A KDM4B | 1.64e-04 | 1178 | 37 | 19 | HP:0002463 |
| HumanPheno | Low posterior hairline | 1.68e-04 | 117 | 37 | 6 | HP:0002162 | |
| HumanPheno | Abnormality of the posterior hairline | 1.68e-04 | 117 | 37 | 6 | HP:0030141 | |
| HumanPheno | Abnormal pinna morphology | KMT2B TCF20 PCLO FGFRL1 SIN3A BCL11A HUWE1 ARID1A CHAMP1 CCNK OPHN1 SH3PXD2B CTCF SETD5 CPLANE1 KAT6B KDM6A UNC80 KDM4B SOS2 | 1.86e-04 | 1299 | 37 | 20 | HP:0000377 |
| HumanPheno | Long nose | 1.97e-04 | 41 | 37 | 4 | HP:0003189 | |
| HumanPheno | Abnormal conjugate eye movement | SETX KMT2B TCF20 FGFRL1 SIN3A BCL11A HUWE1 ARID1A CHAMP1 GATAD2B OPHN1 SYNJ1 CTCF SETD5 CPLANE1 KDM6A UNC80 KDM1A SOS2 | 2.08e-04 | 1198 | 37 | 19 | HP:0000549 |
| HumanPheno | Intellectual disability, severe | KMT2B FGFRL1 SIN3A ARID1A CCNK GATAD2B OPHN1 PHC1 KAT6B UNC80 | 2.18e-04 | 371 | 37 | 10 | HP:0010864 |
| HumanPheno | Epicanthus | KMT2B TCF20 FGFRL1 SIN3A BCL11A HUWE1 CHAMP1 GATAD2B CTCF CPLANE1 KAT6B KDM6A UNC80 | 2.25e-04 | 614 | 37 | 13 | HP:0000286 |
| HumanPheno | Abnormal cerebral subcortex morphology | KMT2B PCLO FGFRL1 SIN3A HUWE1 ARID1A GATAD2B OPHN1 PHC1 SETD2 SH3PXD2B SYNJ1 CTCF CPLANE1 KAT6B KDM6A UNC80 KDM1A KDM4B | 2.31e-04 | 1207 | 37 | 19 | HP:0010993 |
| HumanPheno | Hypospadias | ABL1 FGFRL1 SIN3A HUWE1 ARID1A GATAD2B SETD5 KAT6B KDM6A KDM1A | 2.49e-04 | 377 | 37 | 10 | HP:0000047 |
| HumanPheno | Long fingers | 2.52e-04 | 306 | 37 | 9 | HP:0100807 | |
| HumanPheno | Disinhibition | KMT2B TCF20 SIN3A BCL11A HUWE1 ARID1A CHAMP1 GATAD2B OPHN1 SETD2 SYNJ1 CTCF SETD5 UNC80 KDM4B | 2.63e-04 | 807 | 37 | 15 | HP:0000734 |
| HumanPheno | Inappropriate behavior | KMT2B TCF20 SIN3A BCL11A HUWE1 ARID1A CHAMP1 GATAD2B OPHN1 SETD2 SYNJ1 CTCF SETD5 UNC80 KDM4B | 2.63e-04 | 807 | 37 | 15 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | KMT2B TCF20 SIN3A BCL11A HUWE1 ARID1A CHAMP1 GATAD2B OPHN1 SETD2 SYNJ1 CTCF SETD5 UNC80 KDM4B | 2.63e-04 | 807 | 37 | 15 | HP:5200123 |
| HumanPheno | Social disinhibition | KMT2B TCF20 SIN3A BCL11A HUWE1 ARID1A CHAMP1 GATAD2B OPHN1 SETD2 SYNJ1 CTCF SETD5 UNC80 KDM4B | 2.63e-04 | 807 | 37 | 15 | HP:5200029 |
| HumanPheno | Downturned corners of mouth | 2.75e-04 | 182 | 37 | 7 | HP:0002714 | |
| HumanPheno | Abnormal social development | KMT2B TCF20 SIN3A BCL11A HUWE1 ARID1A CHAMP1 CCNK GATAD2B OPHN1 SETD2 SYNJ1 CTCF SETD5 UNC80 KDM4B | 2.76e-04 | 908 | 37 | 16 | HP:0025732 |
| HumanPheno | Abnormality of the outer ear | KMT2B TCF20 PCLO FGFRL1 SIN3A BCL11A HUWE1 ARID1A CHAMP1 CCNK OPHN1 SH3PXD2B CTCF SETD5 CPLANE1 KAT6B KDM6A UNC80 KDM4B SOS2 | 2.84e-04 | 1337 | 37 | 20 | HP:0000356 |
| HumanPheno | Abnormal mandible morphology | KMT2B FGFRL1 SIN3A BCL11A HUWE1 CCNK GATAD2B OPHN1 SETD2 SH3PXD2B CTCF SETD5 CPLANE1 KAT6B KDM6A UNC80 KDM4B SOS2 | 2.90e-04 | 1118 | 37 | 18 | HP:0000277 |
| HumanPheno | Abnormality of globe location | ABL1 KMT2B TCF20 PCLO FGFRL1 SIN3A HUWE1 CCNK GATAD2B OPHN1 SETD2 SH3PXD2B CTCF CPLANE1 KAT6B KDM6A KDM1A SOS2 | 3.04e-04 | 1122 | 37 | 18 | HP:0100886 |
| HumanPheno | Anterior concavity of thoracic vertebrae | 3.05e-04 | 4 | 37 | 2 | HP:0004611 | |
| HumanPheno | Delayed speech and language development | KMT2B TCF20 SIN3A HUWE1 ARID1A CHAMP1 CCNK OPHN1 SETD2 KCNQ5 SYNJ1 CTCF SETD5 KAT6B KDM6A UNC80 KDM1A KDM4B | 3.07e-04 | 1123 | 37 | 18 | HP:0000750 |
| HumanPheno | Posteriorly rotated ears | KMT2B TCF20 HUWE1 CCNK CTCF CPLANE1 KAT6B KDM6A UNC80 KDM4B SOS2 | 3.40e-04 | 470 | 37 | 11 | HP:0000358 |
| HumanPheno | Abnormality of globe location or size | ABL1 KMT2B TCF20 PCLO FGFRL1 SIN3A HUWE1 CCNK GATAD2B OPHN1 SETD2 SH3PXD2B CTCF SETD5 CPLANE1 KAT6B KDM6A KDM1A SOS2 | 3.60e-04 | 1246 | 37 | 19 | HP:0000489 |
| HumanPheno | Displacement of the urethral meatus | ABL1 FGFRL1 SIN3A HUWE1 ARID1A GATAD2B SETD5 KAT6B KDM6A KDM1A | 3.79e-04 | 397 | 37 | 10 | HP:0100627 |
| HumanPheno | Abnormal male urethral meatus morphology | ABL1 FGFRL1 SIN3A HUWE1 ARID1A GATAD2B SETD5 KAT6B KDM6A KDM1A | 3.94e-04 | 399 | 37 | 10 | HP:0032076 |
| HumanPheno | Abnormal corpus callosum morphology | PCLO FGFRL1 SIN3A HUWE1 ARID1A PHC1 SETD2 SH3PXD2B SYNJ1 CTCF CPLANE1 KAT6B KDM6A UNC80 KDM1A KDM4B | 4.02e-04 | 937 | 37 | 16 | HP:0001273 |
| HumanPheno | Diagnostic behavioral phenotype | KMT2B TCF20 SIN3A BCL11A ARID1A CCNK GATAD2B OPHN1 SETD2 SYNJ1 CTCF SETD5 KDM6A KDM4B | 4.30e-04 | 747 | 37 | 14 | HP:0025783 |
| HumanPheno | Micrognathia | FGFRL1 SIN3A BCL11A HUWE1 GATAD2B SETD2 SH3PXD2B CTCF SETD5 CPLANE1 KAT6B KDM6A UNC80 KDM4B SOS2 | 4.31e-04 | 843 | 37 | 15 | HP:0000347 |
| HumanPheno | Aplasia/Hypoplasia of the mandible | FGFRL1 SIN3A BCL11A HUWE1 GATAD2B SETD2 SH3PXD2B CTCF SETD5 CPLANE1 KAT6B KDM6A UNC80 KDM4B SOS2 | 4.42e-04 | 845 | 37 | 15 | HP:0009118 |
| HumanPheno | Abnormal location of ears | KMT2B TCF20 PCLO BCL11A HUWE1 CHAMP1 CCNK SH3PXD2B CTCF SETD5 CPLANE1 KAT6B KDM6A UNC80 KDM4B SOS2 | 4.44e-04 | 945 | 37 | 16 | HP:0000357 |
| HumanPheno | Tapered finger | 4.63e-04 | 141 | 37 | 6 | HP:0001182 | |
| HumanPheno | Strabismus | SETX KMT2B TCF20 FGFRL1 SIN3A BCL11A HUWE1 ARID1A CHAMP1 GATAD2B OPHN1 CTCF SETD5 CPLANE1 KDM6A UNC80 KDM1A SOS2 | 4.65e-04 | 1159 | 37 | 18 | HP:0000486 |
| HumanPheno | Upslanted palpebral fissure | 4.74e-04 | 333 | 37 | 9 | HP:0000582 | |
| HumanPheno | Bulbous nose | 5.04e-04 | 201 | 37 | 7 | HP:0000414 | |
| HumanPheno | Low-set ears | TCF20 PCLO BCL11A HUWE1 CHAMP1 CCNK SH3PXD2B CTCF SETD5 CPLANE1 KAT6B KDM6A UNC80 KDM4B | 5.23e-04 | 761 | 37 | 14 | HP:0000369 |
| HumanPheno | Brachydactyly | FGFRL1 SIN3A HUWE1 ARID1A GATAD2B SH3PXD2B CTCF SETD5 CPLANE1 KAT6B KDM6A KDM1A SOS2 | 5.39e-04 | 670 | 37 | 13 | HP:0001156 |
| HumanPheno | Short digit | FGFRL1 SIN3A HUWE1 ARID1A GATAD2B SH3PXD2B CTCF SETD5 CPLANE1 KAT6B KDM6A KDM1A SOS2 | 5.55e-04 | 672 | 37 | 13 | HP:0011927 |
| MousePheno | abnormal interventricular septum morphology | ABL1 NACA FGFRL1 HIC2 ARID1A PHC1 NCOR2 SH3PXD2B XIRP2 SETD5 CPLANE1 KDM6A KDM1A | 2.06e-07 | 342 | 88 | 13 | MP:0000281 |
| MousePheno | abnormal myocardial trabeculae morphology | 2.91e-07 | 144 | 88 | 9 | MP:0002189 | |
| MousePheno | abnormal cardiac muscle tissue morphology | ABL1 NACA FGFRL1 HIC2 ARID1A PHC1 SH3PXD2B MAP1S XIRP2 CTCF SETD5 MAPK11 KDM6A HCFC1 KDM1A | 3.51e-07 | 489 | 88 | 15 | MP:0010630 |
| MousePheno | abnormal heart septum morphology | ABL1 NACA FGFRL1 HIC2 ARID1A PHC1 NCOR2 SH3PXD2B XIRP2 SETD5 CPLANE1 KDM6A KDM1A | 8.65e-07 | 388 | 88 | 13 | MP:0006113 |
| MousePheno | abnormal myocardium layer morphology | ABL1 NACA FGFRL1 HIC2 ARID1A SH3PXD2B MAP1S XIRP2 CTCF SETD5 MAPK11 KDM6A HCFC1 | 1.78e-06 | 414 | 88 | 13 | MP:0005329 |
| MousePheno | abnormal heart layer morphology | ABL1 NACA FGFRL1 HIC2 ARID1A SH3PXD2B MAP1S XIRP2 CTCF SETD5 MAPK11 KDM6A HCFC1 | 2.21e-06 | 422 | 88 | 13 | MP:0010545 |
| MousePheno | abnormal heart ventricle morphology | ABL1 FAT3 NACA FGFRL1 HIC2 ARID1A PHC1 NCOR2 SH3PXD2B XIRP2 CTCF SETD5 MAPK11 CPLANE1 KDM6A HCFC1 KDM1A | 7.52e-06 | 793 | 88 | 17 | MP:0005294 |
| MousePheno | ventricular septal defect | 3.79e-05 | 261 | 88 | 9 | MP:0010402 | |
| MousePheno | abnormal muscle morphology | ABL1 FAT3 NACA RAPGEF1 FGFRL1 HIC2 ARID1A TRDN PHC1 SH3PXD2B MAP1S XIRP2 CTCF SETD5 MAPK11 KAT6B KDM6A HCFC1 KDM1A | 4.63e-05 | 1106 | 88 | 19 | MP:0002108 |
| MousePheno | pulmonary valve stenosis | 6.59e-05 | 13 | 88 | 3 | MP:0006128 | |
| MousePheno | abnormal prenatal growth/weight/body size | DLG5 KMT2B TCF20 NACA FGFRL1 HIC2 HUWE1 ARID1A CHAMP1 ADAM10 REXO1 ASAP1 NCOR2 SETD2 ARAP3 CTCF SETD5 DPPA4 CKAP4 CPLANE1 KDM6A HCFC1 | 1.06e-04 | 1493 | 88 | 22 | MP:0004196 |
| MousePheno | muscular ventricular septal defect | 1.22e-04 | 77 | 88 | 5 | MP:0010420 | |
| MousePheno | abnormal interventricular septum muscular part morphology | 1.38e-04 | 79 | 88 | 5 | MP:0010498 | |
| MousePheno | heart right ventricle outflow tract stenosis | 2.17e-04 | 19 | 88 | 3 | MP:0010449 | |
| MousePheno | prenatal growth retardation | DLG5 KMT2B TCF20 NACA FGFRL1 HIC2 HUWE1 CHAMP1 REXO1 ASAP1 NCOR2 SETD2 SETD5 CPLANE1 KDM6A | 3.15e-04 | 869 | 88 | 15 | MP:0010865 |
| MousePheno | abnormal cranium size | 3.60e-04 | 97 | 88 | 5 | MP:0010031 | |
| MousePheno | effusion | 3.90e-04 | 152 | 88 | 6 | MP:0021205 | |
| MousePheno | abnormal cardiovascular development | KMT2B FGFRL1 ARID1A ADAM10 PHC1 ADAMTS12 NCOR2 SETD2 ARAP3 SETD5 CPLANE1 KDM6A DCBLD2 KDM1A | 4.56e-04 | 802 | 88 | 14 | MP:0002925 |
| MousePheno | perinatal lethality, complete penetrance | KMT2B FGFRL1 BCL11A TNRC6C ARID1A GATAD2B PHC1 SYNJ1 CTCF PHACTR4 KDM6A UNC80 KDM1A | 4.88e-04 | 712 | 88 | 13 | MP:0011089 |
| MousePheno | semilunar valve stenosis | 5.64e-04 | 26 | 88 | 3 | MP:0031585 | |
| MousePheno | abnormal heart valve morphology | 5.65e-04 | 163 | 88 | 6 | MP:0000285 | |
| MousePheno | abnormal brain size | 5.77e-04 | 375 | 88 | 9 | MP:0000771 | |
| MousePheno | increased fetal cardiomyocyte proliferation | 5.78e-04 | 6 | 88 | 2 | MP:0011394 | |
| Domain | SH3 | DLG5 AMPH ABL1 CD2AP ASAP1 TXK DOCK5 PRAM1 SH3PXD2B ASAP2 CASKIN1 SH3D19 FYB1 | 1.19e-10 | 216 | 99 | 13 | SM00326 |
| Domain | SH3 | DLG5 AMPH ABL1 CD2AP ASAP1 TXK DOCK5 PRAM1 SH3PXD2B ASAP2 CASKIN1 SH3D19 FYB1 | 1.19e-10 | 216 | 99 | 13 | PS50002 |
| Domain | SH3_domain | DLG5 AMPH ABL1 CD2AP ASAP1 TXK DOCK5 PRAM1 SH3PXD2B ASAP2 CASKIN1 SH3D19 FYB1 | 1.49e-10 | 220 | 99 | 13 | IPR001452 |
| Domain | SH3_1 | 2.19e-07 | 164 | 99 | 9 | PF00018 | |
| Domain | EPHD | 5.05e-06 | 22 | 99 | 4 | PS51805 | |
| Domain | SH3_2 | 6.35e-06 | 86 | 99 | 6 | IPR011511 | |
| Domain | SH3_2 | 6.35e-06 | 86 | 99 | 6 | PF07653 | |
| Domain | PHD | 7.75e-06 | 89 | 99 | 6 | SM00249 | |
| Domain | Znf_PHD | 8.82e-06 | 91 | 99 | 6 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.13e-05 | 95 | 99 | 6 | PS50016 | |
| Domain | ZF_PHD_1 | 1.20e-05 | 96 | 99 | 6 | PS01359 | |
| Domain | Znf_FYVE_PHD | 1.32e-05 | 147 | 99 | 7 | IPR011011 | |
| Domain | PH | 2.97e-05 | 229 | 99 | 8 | PF00169 | |
| Domain | PHD | 4.86e-05 | 75 | 99 | 5 | PF00628 | |
| Domain | hSH3 | 8.32e-05 | 3 | 99 | 2 | IPR029294 | |
| Domain | hSH3 | 8.32e-05 | 3 | 99 | 2 | PF14603 | |
| Domain | PH | 1.16e-04 | 278 | 99 | 8 | SM00233 | |
| Domain | PH_DOMAIN | 1.19e-04 | 279 | 99 | 8 | PS50003 | |
| Domain | PH_domain | 1.22e-04 | 280 | 99 | 8 | IPR001849 | |
| Domain | Cornifin | 1.66e-04 | 4 | 99 | 2 | IPR003302 | |
| Domain | JmjC | 2.70e-04 | 24 | 99 | 3 | PF02373 | |
| Domain | PH_dom-like | 4.34e-04 | 426 | 99 | 9 | IPR011993 | |
| Domain | ArfGap | 4.78e-04 | 29 | 99 | 3 | SM00105 | |
| Domain | ArfGap | 4.78e-04 | 29 | 99 | 3 | PF01412 | |
| Domain | ARFGAP | 4.78e-04 | 29 | 99 | 3 | PS50115 | |
| Domain | ArfGAP | 4.78e-04 | 29 | 99 | 3 | IPR001164 | |
| Domain | - | 5.29e-04 | 30 | 99 | 3 | 1.20.1270.60 | |
| Domain | AH/BAR-dom | 5.29e-04 | 30 | 99 | 3 | IPR027267 | |
| Domain | JMJC | 6.41e-04 | 32 | 99 | 3 | PS51184 | |
| Domain | JmjC_dom | 6.41e-04 | 32 | 99 | 3 | IPR003347 | |
| Domain | JmjC | 7.02e-04 | 33 | 99 | 3 | SM00558 | |
| Domain | Znf_PHD-finger | 8.23e-04 | 79 | 99 | 4 | IPR019787 | |
| Domain | - | 1.12e-03 | 391 | 99 | 8 | 2.30.29.30 | |
| Domain | Peptidase_M12B_N | 1.15e-03 | 39 | 99 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 1.15e-03 | 39 | 99 | 3 | PF01562 | |
| Domain | SAM | 1.23e-03 | 88 | 99 | 4 | SM00454 | |
| Domain | DISINTEGRIN_1 | 1.24e-03 | 40 | 99 | 3 | PS00427 | |
| Domain | Reprolysin | 1.24e-03 | 40 | 99 | 3 | PF01421 | |
| Domain | ADAM_MEPRO | 1.24e-03 | 40 | 99 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 1.24e-03 | 40 | 99 | 3 | PS50214 | |
| Domain | Peptidase_M12B | 1.24e-03 | 40 | 99 | 3 | IPR001590 | |
| Domain | SET | 1.33e-03 | 41 | 99 | 3 | PF00856 | |
| Domain | Disintegrin_dom | 1.33e-03 | 41 | 99 | 3 | IPR001762 | |
| Domain | SAM_DOMAIN | 1.63e-03 | 95 | 99 | 4 | PS50105 | |
| Domain | SAM | 1.77e-03 | 97 | 99 | 4 | IPR001660 | |
| Domain | SET | 1.86e-03 | 46 | 99 | 3 | SM00317 | |
| Domain | UBA | 1.98e-03 | 47 | 99 | 3 | PS50030 | |
| Domain | I-BAR_dom | 2.09e-03 | 13 | 99 | 2 | IPR013606 | |
| Domain | SET_dom | 2.36e-03 | 50 | 99 | 3 | IPR001214 | |
| Domain | SET | 2.36e-03 | 50 | 99 | 3 | PS50280 | |
| Domain | Ras_G-nucl-exch_fac_CS | 2.43e-03 | 14 | 99 | 2 | IPR019804 | |
| Domain | - | 2.44e-03 | 106 | 99 | 4 | 1.10.150.50 | |
| Domain | Post-SET_dom | 3.18e-03 | 16 | 99 | 2 | IPR003616 | |
| Domain | PostSET | 3.18e-03 | 16 | 99 | 2 | SM00508 | |
| Domain | POST_SET | 3.18e-03 | 16 | 99 | 2 | PS50868 | |
| Domain | SAM/pointed | 3.48e-03 | 117 | 99 | 4 | IPR013761 | |
| Domain | RasGEFN | 4.97e-03 | 20 | 99 | 2 | SM00229 | |
| Domain | - | 4.97e-03 | 20 | 99 | 2 | 4.10.70.10 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | BRPF3 KMT2B ARID1A GATAD2B NCOR2 SETD2 KAT6B KDM6A UTY HCFC1 KDM1A KDM4B | 6.22e-11 | 175 | 71 | 12 | MM14941 |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | BRPF3 KMT2B ARID1A GATAD2B NCOR2 SETD2 KAT6B KDM6A UTY HCFC1 KDM1A KDM4B | 9.73e-09 | 272 | 71 | 12 | M29619 |
| Pathway | REACTOME_HDMS_DEMETHYLATE_HISTONES | 1.28e-05 | 29 | 71 | 4 | MM14934 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | DLG5 ABL1 RAPGEF1 PRAG1 OPHN1 DOCK5 ARAP3 RHOBTB1 SLITRK5 CKAP4 MAPK11 KDM1A SOS2 | 5.38e-05 | 720 | 71 | 13 | M41838 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | DLG5 RAPGEF1 PRAG1 OPHN1 DOCK5 ARAP3 RHOBTB1 SLITRK5 CKAP4 SOS2 | 6.53e-05 | 439 | 71 | 10 | MM15595 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | DLG5 RAPGEF1 PRAG1 OPHN1 DOCK5 ARAP3 RHOBTB1 SLITRK5 CKAP4 SOS2 | 8.03e-05 | 450 | 71 | 10 | M27078 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | DLG5 ABL1 RAPGEF1 PRAG1 OPHN1 DOCK5 ARAP3 RHOBTB1 SLITRK5 CKAP4 MAPK11 SOS2 | 8.65e-05 | 649 | 71 | 12 | MM15690 |
| Pathway | REACTOME_HDMS_DEMETHYLATE_HISTONES | 1.14e-04 | 50 | 71 | 4 | M27232 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 1.30e-04 | 301 | 71 | 8 | MM15983 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | BRPF3 ABL1 INTS12 KMT2B SIN3A ARID1A CCNK GATAD2B PHC1 NCOR2 CTCF MAPK11 KDM6A HCFC1 | 4.94e-04 | 1022 | 71 | 14 | MM15436 |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 5.47e-04 | 32 | 71 | 3 | M27900 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KMT2B TCF20 RAPH1 SIN3A HUWE1 CHAMP1 FAM53C CCNK REXO1 GATAD2B NCOR2 SETD2 SH2D4A RPAP1 MAP1S MAP4K1 PHACTR4 ZBTB21 RBM6 KAT6B KDM6A PRRC2A KDM4B | 4.47e-17 | 774 | 101 | 23 | 15302935 |
| Pubmed | KMT2B TCF20 RAPH1 CD2AP SIN3A HUWE1 ARID1A CHAMP1 CCNK SETD2 SH3PXD2B SYNJ1 SH3D19 PHACTR4 KDM6A PRRC2A HCFC1 KDM1A | 3.13e-14 | 549 | 101 | 18 | 38280479 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DLG5 SETX ABL1 INTS12 TCF20 RAPH1 CD2AP PRAG1 FAM53C C6orf132 SH3PXD2B KCNQ5 SYNJ1 CEP89 MAP4K1 SH3D19 PHACTR4 ZBTB21 CAMSAP2 UTRN | 6.10e-13 | 861 | 101 | 20 | 36931259 |
| Pubmed | Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS. | 3.15e-11 | 108 | 101 | 9 | 19531213 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABL1 KMT2B RAPGEF1 FGFRL1 TNRC6C HUWE1 ARID1A PRAG1 REXO1 C6orf132 NCOR2 SH3PXD2B ARAP3 RPAP1 MAP1S SYNJ1 ZNF827 SETD5 CASKIN1 HCFC1 | 5.41e-11 | 1105 | 101 | 20 | 35748872 |
| Pubmed | The proximal signaling network of the BCR-ABL1 oncogene shows a modular organization. | 1.03e-10 | 81 | 101 | 8 | 20697350 | |
| Pubmed | BRPF3 FAT3 HIC2 SIN3A BCL11A ARID1A CHAMP1 FAM53C GATAD2B NCOR2 SETD2 ZNF827 CTCF SETD5 ZBTB21 CKAP4 KAT6B UNC80 KDM1A | 4.86e-10 | 1116 | 101 | 19 | 31753913 | |
| Pubmed | KMT2B TCF20 RAPH1 CD2AP HUWE1 CHAMP1 PHC1 NCOR2 SYNJ1 ZBTB21 UTRN KDM1A | 3.53e-09 | 418 | 101 | 12 | 34709266 | |
| Pubmed | DENND2A DLG5 BRPF3 SETX NACA HIC2 CHAMP1 CEMIP2 CASKIN1 ZBTB21 KAT6B KDM1A KDM4B | 4.86e-09 | 529 | 101 | 13 | 14621295 | |
| Pubmed | INTS12 TCF20 SIN3A ARID1A CHAMP1 CCNK ZBTB21 KDM6A HCFC1 KDM1A | 6.48e-09 | 268 | 101 | 10 | 33640491 | |
| Pubmed | 1.66e-08 | 57 | 101 | 6 | 18022353 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.74e-08 | 220 | 101 | 9 | 35785414 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | KMT2B SPRR1B SIN3A BCL11A CHAMP1 FAM53C GATAD2B PHC1 CKAP4 KDM6A HCFC1 KDM1A | 2.29e-08 | 495 | 101 | 12 | 27705803 |
| Pubmed | 3.26e-08 | 12 | 101 | 4 | 35192416 | ||
| Pubmed | 4.49e-08 | 329 | 101 | 10 | 17474147 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CD2AP FGFRL1 TNRC6C HUWE1 ARID1A DOCK5 NCOR2 ATF6 ASAP2 KCNQ5 ZNF827 SETD5 TTLL11 RBM6 KAT6B UTRN KDM6A KDM4B SOS2 | 5.12e-08 | 1489 | 101 | 19 | 28611215 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SIN3A ASAP1 C6orf132 DOCK5 NCOR2 ASAP2 MAP1S XIRP2 DPPA4 MAP4K1 SOS2 | 5.33e-08 | 430 | 101 | 11 | 35044719 |
| Pubmed | DLG5 FAM184A SETX INTS12 KMT2B CD2AP NACA CCNK GATAD2B C6orf132 SETD2 CTCF SETD5 CRACDL RBM6 CAMSAP2 UTRN PRRC2A KDM1A | 5.57e-08 | 1497 | 101 | 19 | 31527615 | |
| Pubmed | RAPH1 CD2AP NACA HUWE1 OPHN1 ASAP1 DOCK5 ASAP2 ARAP3 RBM6 CKAP4 UTRN PRRC2A KDM1A SOS2 | 6.57e-08 | 916 | 101 | 15 | 32203420 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | DLG5 RAPH1 CD2AP CEMIP2 ASAP1 C6orf132 SH3PXD2B SYNJ1 SH3D19 PHACTR4 UTRN HCFC1 | 9.66e-08 | 565 | 101 | 12 | 25468996 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SETX TCF20 CD2AP ARID1A CHAMP1 CCNK GATAD2B PRAM1 NCOR2 SETD2 CTCF RBM6 CKAP4 PRRC2A HCFC1 | 1.11e-07 | 954 | 101 | 15 | 36373674 |
| Pubmed | SETX INTS12 KMT2B TCF20 SIN3A BCL11A ARID1A CCNK GATAD2B PRAM1 NCOR2 ZBTB21 KDM6A PRRC2A HCFC1 KDM1A | 1.20e-07 | 1103 | 101 | 16 | 34189442 | |
| Pubmed | CTTNBP2 TCF20 BCL11A HUWE1 GATAD2B NCOR2 SH3PXD2B SYNJ1 CTCF CASKIN1 SH3D19 ZBTB21 CAMSAP2 PRRC2A KDM1A | 1.25e-07 | 963 | 101 | 15 | 28671696 | |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 1.37e-07 | 134 | 101 | 7 | 25452129 | |
| Pubmed | INTS12 KMT2B TCF20 NACA HIC2 SIN3A BCL11A TNRC6C ARID1A GATAD2B NCOR2 CTCF ZBTB21 RBM6 KDM6A PRRC2A HCFC1 KDM1A | 1.47e-07 | 1429 | 101 | 18 | 35140242 | |
| Pubmed | SETX TCF20 RAPGEF1 FAM53C ASAP1 ATF6 ASAP2 SH2D4A SH3D19 CPLANE1 SOS2 | 1.82e-07 | 486 | 101 | 11 | 20936779 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SETX INTS12 KMT2B TCF20 SIN3A CHAMP1 GATAD2B PHC1 ZBTB21 HCFC1 KDM1A KDM4B | 2.12e-07 | 608 | 101 | 12 | 36089195 |
| Pubmed | The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins. | 2.37e-07 | 5 | 101 | 3 | 9067577 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 2.46e-07 | 146 | 101 | 7 | 23892456 | |
| Pubmed | Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition. | 3.86e-07 | 21 | 101 | 4 | 27626377 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RAPH1 NACA SIN3A CHAMP1 CCNK SETD2 SYNJ1 CTCF SH3D19 ZBTB21 CAMSAP2 UTRN PRRC2A HCFC1 | 5.42e-07 | 934 | 101 | 14 | 33916271 |
| Pubmed | 5.88e-07 | 103 | 101 | 6 | 21706016 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 6.11e-07 | 167 | 101 | 7 | 20362541 | |
| Pubmed | 6.41e-07 | 246 | 101 | 8 | 15345747 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SETX INTS12 KMT2B TCF20 SIN3A ARID1A CHAMP1 GATAD2B DOCK5 NCOR2 SETD2 CTCF CKAP4 KDM6A HCFC1 KDM1A | 1.00e-06 | 1294 | 101 | 16 | 30804502 |
| Pubmed | DLG5 TCF20 RAPH1 NACA ARID1A CHAMP1 CCNK ASAP1 SH3PXD2B CTCF | 1.23e-06 | 472 | 101 | 10 | 38943005 | |
| Pubmed | Role of PML and PML-RARalpha in Mad-mediated transcriptional repression. | 1.32e-06 | 8 | 101 | 3 | 11430826 | |
| Pubmed | 1.97e-06 | 9 | 101 | 3 | 14679214 | ||
| Pubmed | 2.44e-06 | 396 | 101 | 9 | 26687479 | ||
| Pubmed | Phospho-tyrosine dependent protein-protein interaction network. | 3.23e-06 | 410 | 101 | 9 | 25814554 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 3.30e-06 | 411 | 101 | 9 | 35182466 | |
| Pubmed | 3.33e-06 | 78 | 101 | 5 | 28611094 | ||
| Pubmed | 3.86e-06 | 11 | 101 | 3 | 32467224 | ||
| Pubmed | 4.53e-06 | 83 | 101 | 5 | 28794006 | ||
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 5.27e-06 | 150 | 101 | 6 | 28242625 | |
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 5.65e-06 | 40 | 101 | 4 | 34585037 | |
| Pubmed | 6.84e-06 | 157 | 101 | 6 | 30186101 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DLG5 FAM184A RAPH1 CD2AP TNRC6C ASAP1 SH3PXD2B SH2D4A SYNJ1 PHACTR4 CPLANE1 CAMSAP2 | 7.09e-06 | 853 | 101 | 12 | 28718761 |
| Pubmed | 8.32e-06 | 44 | 101 | 4 | 24183668 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 20581864 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 29741645 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 7968380 | ||
| Pubmed | MiR-463-3p inhibits tibial nerve regeneration via post-transcriptional suppression of SPRR1A. | 8.35e-06 | 2 | 101 | 2 | 31468997 | |
| Pubmed | Transcriptional repression by the insulator protein CTCF involves histone deacetylases. | 8.35e-06 | 2 | 101 | 2 | 10734189 | |
| Pubmed | An H-YDb epitope is encoded by a novel mouse Y chromosome gene. | 8.35e-06 | 2 | 101 | 2 | 8944031 | |
| Pubmed | Setd5, but not Setd2, is indispensable for retinal cell survival and proliferation. | 8.35e-06 | 2 | 101 | 2 | 36349512 | |
| Pubmed | SPRR1B overexpression enhances entry of cells into the G0 phase of the cell cycle. | 8.35e-06 | 2 | 101 | 2 | 12832281 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 18434530 | ||
| Pubmed | let-7 miRNAs repress HIC2 to regulate BCL11A transcription and hemoglobin switching. | 8.35e-06 | 2 | 101 | 2 | 38364109 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 22347474 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 37894817 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 27533081 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 10771479 | ||
| Pubmed | Role of the HCF-1 basic region in sustaining cell proliferation. | 8.35e-06 | 2 | 101 | 2 | 20126307 | |
| Pubmed | HIC2 controls developmental hemoglobin switching by repressing BCL11A transcription. | 8.35e-06 | 2 | 101 | 2 | 35941187 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 15758204 | ||
| Pubmed | Lysine demethylases KDM6A and UTY: The X and Y of histone demethylation. | 8.35e-06 | 2 | 101 | 2 | 31097364 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 32879445 | ||
| Pubmed | Triadin and CLIMP-63 form a link between triads and microtubules in muscle cells. | 8.35e-06 | 2 | 101 | 2 | 27562070 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 19107756 | ||
| Pubmed | Structure and organization of the genes encoding mouse small proline-rich proteins, mSPRR1A and 1B. | 8.35e-06 | 2 | 101 | 2 | 9931436 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 19097987 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 11278340 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 16831444 | ||
| Pubmed | Sequence and expression patterns of mouse SPR1: Correlation of expression with epithelial function. | 8.35e-06 | 2 | 101 | 2 | 8601731 | |
| Pubmed | Lymphotoxin-beta regulates periderm differentiation during embryonic skin development. | 8.45e-06 | 14 | 101 | 3 | 17673451 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 8.56e-06 | 588 | 101 | 10 | 38580884 | |
| Pubmed | 9.06e-06 | 251 | 101 | 7 | 31076518 | ||
| Pubmed | Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes. | 9.11e-06 | 45 | 101 | 4 | 21258344 | |
| Pubmed | RAPH1 HUWE1 ARID1A CEMIP2 ASAP1 NCOR2 SH2D4A CEP89 CKAP4 MAPK11 UTRN KDM6A PRRC2A | 1.11e-05 | 1049 | 101 | 13 | 27880917 | |
| Pubmed | 1.28e-05 | 49 | 101 | 4 | 34368113 | ||
| Pubmed | 1.39e-05 | 50 | 101 | 4 | 37974198 | ||
| Pubmed | DENND2A AMPH CTTNBP2 PCLO BCL11A ARID1A OPHN1 ASAP1 MAP1S SYNJ1 CRACDL CASKIN1 CAMSAP2 UTRN PRRC2A | 1.63e-05 | 1431 | 101 | 15 | 37142655 | |
| Pubmed | 1.66e-05 | 503 | 101 | 9 | 16964243 | ||
| Pubmed | Sox2 cooperates with Chd7 to regulate genes that are mutated in human syndromes. | 1.76e-05 | 53 | 101 | 4 | 21532573 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 2.04e-05 | 394 | 101 | 8 | 27248496 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 2.19e-05 | 398 | 101 | 8 | 35016035 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 2.25e-05 | 289 | 101 | 7 | 23752268 | |
| Pubmed | 2.35e-05 | 57 | 101 | 4 | 38223760 | ||
| Pubmed | INTS12 TCF20 ARID1A GATAD2B PHC1 CTCF ZBTB21 KAT6B KDM6A UTY KDM4B | 2.37e-05 | 808 | 101 | 11 | 20412781 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 11850458 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 16443220 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 18093523 | ||
| Pubmed | c-Abl phosphorylates Dok1 to promote filopodia during cell spreading. | 2.50e-05 | 3 | 101 | 2 | 15148308 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 22951486 | ||
| Pubmed | Tyrosine phosphorylation of p62dok by p210bcr-abl inhibits RasGAP activity. | 2.50e-05 | 3 | 101 | 2 | 10688886 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 37468478 | ||
| Pubmed | Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok. | 2.50e-05 | 3 | 101 | 2 | 9008161 | |
| Pubmed | Dimerization of the Pragmin Pseudo-Kinase Regulates Protein Tyrosine Phosphorylation. | 2.50e-05 | 3 | 101 | 2 | 29503074 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 7829876 | ||
| Interaction | CRK interactions | DOK1 ABL1 CD2AP RAPGEF1 HUWE1 PEAK3 PRAG1 ASAP1 TXK DOCK5 C4orf17 CEP89 DPPA4 MAP4K1 PHACTR4 KDM1A SOS2 | 4.17e-12 | 370 | 101 | 17 | int:CRK |
| Interaction | GRB2 interactions | DOK1 ABL1 GGN CD2AP RAPGEF1 PRR22 HUWE1 PEAK3 ADAM10 PRAG1 ASAP1 TXK DOCK5 SH3PXD2B ASAP2 SH2D4A SYNJ1 DPPA4 MAP4K1 SH3D19 PHACTR4 PRRC2A SOS2 | 8.63e-12 | 806 | 101 | 23 | int:GRB2 |
| Interaction | SH3KBP1 interactions | DENND2A ABL1 RAPH1 GGN CD2AP ASAP1 SH3PXD2B ASAP2 ARAP3 SYNJ1 SH3D19 PHACTR4 CKAP4 PRRC2A | 5.89e-10 | 315 | 101 | 14 | int:SH3KBP1 |
| Interaction | NCK2 interactions | DOK1 RAPH1 GGN BCL11A FAM53C ASAP1 TXK C4orf17 SH3PXD2B ASAP2 MAP4K1 FYB1 PRRC2A | 6.65e-10 | 262 | 101 | 13 | int:NCK2 |
| Interaction | CRKL interactions | DOK1 ABL1 RAPGEF1 HUWE1 PEAK3 PRAG1 ASAP1 DOCK5 MAP4K1 KDM1A SOS2 | 1.90e-08 | 227 | 101 | 11 | int:CRKL |
| Interaction | H2BC21 interactions | CYLC1 BRPF3 KMT2B TCF20 PCLO HUWE1 ARID1A CHAMP1 GATAD2B PHC1 MAP4K1 CKAP4 KAT6B FYB1 PRRC2A HCFC1 KDM1A | 6.21e-08 | 696 | 101 | 17 | int:H2BC21 |
| Interaction | WWTR1 interactions | TCF20 RAPH1 CD2AP SIN3A ARID1A SETD2 SH3PXD2B SYNJ1 SH3D19 PHACTR4 KDM6A PRRC2A HCFC1 | 1.90e-07 | 422 | 101 | 13 | int:WWTR1 |
| Interaction | PEAK3 interactions | 2.85e-07 | 12 | 101 | 4 | int:PEAK3 | |
| Interaction | TERF2IP interactions | SETX KMT2B TCF20 ARID1A CHAMP1 GATAD2B PHC1 NCOR2 SETD2 RPAP1 CTCF ZBTB21 HCFC1 KDM1A | 6.54e-07 | 552 | 101 | 14 | int:TERF2IP |
| Interaction | TFCP2L1 interactions | 6.57e-07 | 99 | 101 | 7 | int:TFCP2L1 | |
| Interaction | RUNX1 interactions | HIC2 SIN3A ARID1A CCNK GATAD2B PHC1 NCOR2 FAM222B KAT6B PRRC2A HCFC1 | 6.87e-07 | 324 | 101 | 11 | int:RUNX1 |
| Interaction | SAP30 interactions | 1.97e-06 | 167 | 101 | 8 | int:SAP30 | |
| Interaction | YWHAH interactions | DLG5 SETX ABL1 INTS12 TCF20 CD2AP HUWE1 PRAG1 FAM53C C6orf132 SH3PXD2B KCNQ5 SYNJ1 CEP89 SH3D19 PHACTR4 ZBTB21 CAMSAP2 UTRN | 2.03e-06 | 1102 | 101 | 19 | int:YWHAH |
| Interaction | POU5F1 interactions | TCF20 NACA SIN3A HUWE1 ARID1A GATAD2B PHC1 PRAM1 NCOR2 ATF6 DPPA4 HCFC1 KDM1A | 7.03e-06 | 584 | 101 | 13 | int:POU5F1 |
| Interaction | FEV interactions | 8.37e-06 | 203 | 101 | 8 | int:FEV | |
| Interaction | RBBP7 interactions | TCF20 SIN3A BCL11A HUWE1 ARID1A GATAD2B NCOR2 ARAP3 ZNF827 CTCF HCFC1 KDM1A | 8.83e-06 | 507 | 101 | 12 | int:RBBP7 |
| Interaction | TOP3B interactions | ABL1 KMT2B RAPGEF1 FGFRL1 TNRC6C HUWE1 ARID1A PRAG1 REXO1 C6orf132 NCOR2 SH3PXD2B ARAP3 RPAP1 MAP1S SYNJ1 ZNF827 SETD5 CASKIN1 PRRC2A HCFC1 | 1.04e-05 | 1470 | 101 | 21 | int:TOP3B |
| Interaction | SOS2 interactions | 1.16e-05 | 59 | 101 | 5 | int:SOS2 | |
| Interaction | RBBP5 interactions | 1.41e-05 | 287 | 101 | 9 | int:RBBP5 | |
| Interaction | KDM1A interactions | DLG5 KMT2B TCF20 RAPH1 CD2AP SIN3A HUWE1 CHAMP1 PHC1 C4orf17 NCOR2 SYNJ1 SH3D19 ZBTB21 UTRN KDM1A | 1.72e-05 | 941 | 101 | 16 | int:KDM1A |
| Interaction | MAPRE3 interactions | 2.07e-05 | 230 | 101 | 8 | int:MAPRE3 | |
| Interaction | SIN3A interactions | BRPF3 TCF20 SIN3A BCL11A ARID1A GATAD2B NCOR2 CTCF HCFC1 KDM1A | 2.11e-05 | 380 | 101 | 10 | int:SIN3A |
| Interaction | ARHGAP12 interactions | 2.32e-05 | 68 | 101 | 5 | int:ARHGAP12 | |
| Interaction | SH3D19 interactions | 2.49e-05 | 69 | 101 | 5 | int:SH3D19 | |
| Interaction | NANOG interactions | KMT2B TCF20 SIN3A HUWE1 ARID1A GATAD2B PHC1 PRAM1 NCOR2 HCFC1 KDM1A | 2.94e-05 | 481 | 101 | 11 | int:NANOG |
| Interaction | NCK1 interactions | 3.16e-05 | 244 | 101 | 8 | int:NCK1 | |
| Interaction | BCR interactions | 3.16e-05 | 244 | 101 | 8 | int:BCR | |
| Interaction | HDAC1 interactions | KMT2B TCF20 RAPH1 CD2AP SIN3A BCL11A ARID1A GATAD2B NCOR2 SYNJ1 ZNF827 CTCF ZBTB21 MAPK11 UTRN HCFC1 KDM1A | 3.40e-05 | 1108 | 101 | 17 | int:HDAC1 |
| Interaction | PHF20L1 interactions | 3.74e-05 | 75 | 101 | 5 | int:PHF20L1 | |
| Interaction | RCOR1 interactions | KMT2B RAPH1 CD2AP SIN3A HUWE1 NCOR2 SYNJ1 ZNF827 ZBTB21 UTRN KDM1A | 3.74e-05 | 494 | 101 | 11 | int:RCOR1 |
| Interaction | SHANK3 interactions | AMPH CTTNBP2 TCF20 NACA ADAM10 SETD2 SH3PXD2B MAP1S SYNJ1 XIRP2 CASKIN1 | 3.88e-05 | 496 | 101 | 11 | int:SHANK3 |
| Interaction | BIN1 interactions | 4.72e-05 | 129 | 101 | 6 | int:BIN1 | |
| Interaction | ABL1 interactions | 4.82e-05 | 259 | 101 | 8 | int:ABL1 | |
| Interaction | SORBS3 interactions | 7.11e-05 | 202 | 101 | 7 | int:SORBS3 | |
| Interaction | GOLGA2 interactions | FAM184A CTTNBP2 TCF20 GGN SIN3A BCL11A GATAD2B PRAM1 NCOR2 SH2D4A ZBTB21 KDM6A KDM1A | 7.51e-05 | 733 | 101 | 13 | int:GOLGA2 |
| Interaction | SUDS3 interactions | 7.74e-05 | 141 | 101 | 6 | int:SUDS3 | |
| Interaction | SH3GL2 interactions | 8.06e-05 | 88 | 101 | 5 | int:SH3GL2 | |
| Interaction | SH3GL3 interactions | 9.04e-05 | 145 | 101 | 6 | int:SH3GL3 | |
| Interaction | ELF5 interactions | 9.75e-05 | 147 | 101 | 6 | int:ELF5 | |
| Interaction | CD2AP interactions | 1.02e-04 | 214 | 101 | 7 | int:CD2AP | |
| Interaction | EZR interactions | DLG5 RAPH1 BCL11A ADAM10 ASAP1 C6orf132 SH2D4A SYNJ1 SH3D19 PHACTR4 UTRN | 1.03e-04 | 553 | 101 | 11 | int:EZR |
| Interaction | HDAC2 interactions | TCF20 SPRR1B SIN3A BCL11A HUWE1 ARID1A GATAD2B PHC1 NCOR2 ZNF827 CKAP4 KDM6A HCFC1 KDM1A | 1.03e-04 | 865 | 101 | 14 | int:HDAC2 |
| Interaction | RERE interactions | 1.05e-04 | 93 | 101 | 5 | int:RERE | |
| Interaction | KANSL1 interactions | 1.22e-04 | 96 | 101 | 5 | int:KANSL1 | |
| Interaction | SMC5 interactions | SETX TCF20 CD2AP ARID1A CHAMP1 CCNK GATAD2B PRAM1 NCOR2 SETD2 CTCF RBM6 CKAP4 PRRC2A HCFC1 | 1.33e-04 | 1000 | 101 | 15 | int:SMC5 |
| Interaction | RBBP4 interactions | TCF20 SIN3A BCL11A HUWE1 ARID1A CHAMP1 GATAD2B ZNF827 CTCF HCFC1 KDM1A | 1.40e-04 | 573 | 101 | 11 | int:RBBP4 |
| Interaction | SP7 interactions | 1.47e-04 | 304 | 101 | 8 | int:SP7 | |
| Interaction | YWHAG interactions | DLG5 ABL1 RAPH1 CD2AP HUWE1 PRAG1 FAM53C C6orf132 KCNQ5 SYNJ1 CEP89 SH3D19 PHACTR4 ZBTB21 EFCAB7 CAMSAP2 UTRN | 1.47e-04 | 1248 | 101 | 17 | int:YWHAG |
| Interaction | KLF3 interactions | 1.51e-04 | 228 | 101 | 7 | int:KLF3 | |
| Interaction | SKAP1 interactions | 1.62e-04 | 102 | 101 | 5 | int:SKAP1 | |
| Interaction | LRRK1 interactions | 1.62e-04 | 102 | 101 | 5 | int:LRRK1 | |
| Interaction | LCP2 interactions | 1.67e-04 | 55 | 101 | 4 | int:LCP2 | |
| Interaction | BACC1 interactions | 1.78e-04 | 104 | 101 | 5 | int:BACC1 | |
| Interaction | GRAP2 interactions | 1.78e-04 | 104 | 101 | 5 | int:GRAP2 | |
| Interaction | H3C3 interactions | SETX INTS12 KMT2B TCF20 SIN3A CHAMP1 GATAD2B PHC1 KDM1A KDM4B | 1.90e-04 | 495 | 101 | 10 | int:H3C3 |
| Interaction | PPFIA3 interactions | 1.91e-04 | 57 | 101 | 4 | int:PPFIA3 | |
| Interaction | SYNJ1 interactions | 1.94e-04 | 106 | 101 | 5 | int:SYNJ1 | |
| Interaction | KMT2D interactions | 2.09e-04 | 169 | 101 | 6 | int:KMT2D | |
| Interaction | SETD1A interactions | 2.16e-04 | 170 | 101 | 6 | int:SETD1A | |
| Interaction | SRGAP3 interactions | 2.19e-04 | 59 | 101 | 4 | int:SRGAP3 | |
| Interaction | PHF12 interactions | 2.31e-04 | 110 | 101 | 5 | int:PHF12 | |
| Interaction | SOCS3 interactions | 2.31e-04 | 110 | 101 | 5 | int:SOCS3 | |
| Interaction | MTA3 interactions | 2.37e-04 | 173 | 101 | 6 | int:MTA3 | |
| Interaction | SORBS2 interactions | 2.41e-04 | 111 | 101 | 5 | int:SORBS2 | |
| Interaction | KAT14 interactions | 2.51e-04 | 112 | 101 | 5 | int:KAT14 | |
| Interaction | ASF1A interactions | 2.59e-04 | 249 | 101 | 7 | int:ASF1A | |
| Interaction | H2BC18 interactions | 2.93e-04 | 180 | 101 | 6 | int:H2BC18 | |
| Interaction | TBXT interactions | 2.96e-04 | 116 | 101 | 5 | int:TBXT | |
| Interaction | ALG13 interactions | 3.21e-04 | 183 | 101 | 6 | int:ALG13 | |
| Interaction | YAP1 interactions | ABL1 KMT2B TCF20 CD2AP SIN3A HUWE1 ARID1A CHAMP1 CCNK SETD2 SH3D19 KDM6A PRRC2A HCFC1 KDM1A | 3.55e-04 | 1095 | 101 | 15 | int:YAP1 |
| Interaction | NAA40 interactions | RAPH1 NACA SIN3A CHAMP1 CCNK SETD2 SYNJ1 CTCF SH3D19 ZBTB21 CAMSAP2 UTRN PRRC2A HCFC1 | 3.66e-04 | 978 | 101 | 14 | int:NAA40 |
| Interaction | ZNF827 interactions | 4.06e-04 | 29 | 101 | 3 | int:ZNF827 | |
| Interaction | BRMS1L interactions | 4.17e-04 | 125 | 101 | 5 | int:BRMS1L | |
| Interaction | AR interactions | ABL1 INTS12 TCF20 SIN3A HUWE1 ARID1A CHAMP1 CCNK GATAD2B NCOR2 ZBTB21 KDM6A HCFC1 KDM1A | 4.22e-04 | 992 | 101 | 14 | int:AR |
| Interaction | MBD3L1 interactions | 4.23e-04 | 70 | 101 | 4 | int:MBD3L1 | |
| Interaction | HCLS1 interactions | 4.46e-04 | 71 | 101 | 4 | int:HCLS1 | |
| Interaction | KLF5 interactions | 4.49e-04 | 195 | 101 | 6 | int:KLF5 | |
| Interaction | CEBPA interactions | SETX INTS12 KMT2B TCF20 SIN3A BCL11A ARID1A CCNK GATAD2B PRAM1 NCOR2 ZBTB21 KDM6A PRRC2A HCFC1 KDM1A | 4.50e-04 | 1245 | 101 | 16 | int:CEBPA |
| Interaction | CDH1 interactions | DLG5 RAPH1 CD2AP CEMIP2 ASAP1 C6orf132 SH3PXD2B SYNJ1 SH3D19 PHACTR4 UTRN HCFC1 | 4.59e-04 | 768 | 101 | 12 | int:CDH1 |
| Interaction | PPIA interactions | DLG5 ABL1 TCF20 RAPH1 NACA HUWE1 ARID1A CHAMP1 CCNK ASAP1 SH3PXD2B CTCF HCFC1 | 4.88e-04 | 888 | 101 | 13 | int:PPIA |
| Interaction | PAX9 interactions | 4.99e-04 | 130 | 101 | 5 | int:PAX9 | |
| Interaction | TNRC6A interactions | 5.24e-04 | 280 | 101 | 7 | int:TNRC6A | |
| Interaction | H3C1 interactions | GARIN5B KMT2B NACA SIN3A CHAMP1 GATAD2B SETD2 XIRP2 CTCF CKAP4 KAT6B KDM6A KDM1A | 5.60e-04 | 901 | 101 | 13 | int:H3C1 |
| Interaction | DPY30 interactions | 5.70e-04 | 204 | 101 | 6 | int:DPY30 | |
| Interaction | KMT2C interactions | 5.73e-04 | 134 | 101 | 5 | int:KMT2C | |
| Interaction | SSX2IP interactions | 6.20e-04 | 288 | 101 | 7 | int:SSX2IP | |
| Interaction | REPS2 interactions | 6.53e-04 | 34 | 101 | 3 | int:REPS2 | |
| Interaction | SOX2 interactions | DLG5 TCF20 SIN3A ARID1A CHAMP1 CCNK GATAD2B NCOR2 ATF6 SETD2 CTCF CKAP4 CPLANE1 KAT6B EFCAB7 KDM6A KDM1A | 6.70e-04 | 1422 | 101 | 17 | int:SOX2 |
| Interaction | H2BC17 interactions | 6.99e-04 | 140 | 101 | 5 | int:H2BC17 | |
| Interaction | DPPA4 interactions | 6.99e-04 | 140 | 101 | 5 | int:DPPA4 | |
| Interaction | VASP interactions | 7.00e-04 | 294 | 101 | 7 | int:VASP | |
| Interaction | SOX7 interactions | 7.70e-04 | 82 | 101 | 4 | int:SOX7 | |
| Interaction | NCOA6 interactions | 8.19e-04 | 145 | 101 | 5 | int:NCOA6 | |
| Cytoband | 19p13.3 | 1.86e-04 | 237 | 101 | 5 | 19p13.3 | |
| Cytoband | 1q21-q22 | 1.18e-03 | 23 | 101 | 2 | 1q21-q22 | |
| Cytoband | 8p21.2 | 1.39e-03 | 25 | 101 | 2 | 8p21.2 | |
| Cytoband | 6q22.31 | 1.62e-03 | 27 | 101 | 2 | 6q22.31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.94e-03 | 797 | 101 | 7 | chr19p13 | |
| Cytoband | 1p35.3 | 2.57e-03 | 34 | 101 | 2 | 1p35.3 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 1.27e-06 | 24 | 62 | 4 | 485 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 2.52e-05 | 17 | 62 | 3 | 1291 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 7.35e-05 | 206 | 62 | 6 | 682 | |
| GeneFamily | ArfGAPs | 1.95e-04 | 33 | 62 | 3 | 395 | |
| GeneFamily | Sterile alpha motif domain containing | 2.36e-04 | 88 | 62 | 4 | 760 | |
| GeneFamily | PHD finger proteins | 2.57e-04 | 90 | 62 | 4 | 88 | |
| GeneFamily | Small proline rich proteins | 6.24e-04 | 11 | 62 | 2 | 1353 | |
| GeneFamily | Ankyrin repeat domain containing | 1.43e-03 | 242 | 62 | 5 | 403 | |
| GeneFamily | Cadherin related | 1.52e-03 | 17 | 62 | 2 | 24 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 3.30e-03 | 25 | 62 | 2 | 775 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 3.84e-03 | 27 | 62 | 2 | 47 | |
| GeneFamily | SH2 domain containing | 5.04e-03 | 101 | 62 | 3 | 741 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 6.05e-03 | 34 | 62 | 2 | 487 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 1.10e-02 | 134 | 62 | 3 | 861 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | DENND2A AMPH FAM184A BRPF3 INTS12 FAT3 HIC2 BCL11A ARID1A CEMIP2 PHC1 SYNJ1 CTCF SETD5 MAPK11 CPLANE1 EFCAB7 KDM6A KDM4B SOS2 | 5.07e-06 | 1370 | 100 | 20 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.93e-07 | 193 | 101 | 7 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.14e-07 | 195 | 101 | 7 | d70b49f6b9c6c4422adb2936c837a1af7569fb0a | |
| ToppCell | (3)_ILC|World / shred on Cell_type and subtype | 3.73e-07 | 200 | 101 | 7 | 03554b3f323785b1e0b48fa32de0d92065dd798e | |
| ToppCell | (30)_ILC|World / shred on Cell_type and subtype | 4.26e-07 | 204 | 101 | 7 | bd9fbd278c05e396463704d711b60d47699e3c09 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.72e-06 | 182 | 101 | 6 | b86690c109cdc16844a6cd2216c1bf2bf28efd45 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-06 | 185 | 101 | 6 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.21e-06 | 186 | 101 | 6 | 855c2e5a8a6cf94c7de31982e0e2416f924439d3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.48e-06 | 188 | 101 | 6 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 5.06e-06 | 192 | 101 | 6 | e16035b3328f9b1b2e28d234c62ba88387540550 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 5.21e-06 | 193 | 101 | 6 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | background-NK_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 5.21e-06 | 193 | 101 | 6 | f8d6eff1e04926f85d265ec39fe66897fe29574d | |
| ToppCell | T_cells-CD56_bright_CD16-_NK_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 5.21e-06 | 193 | 101 | 6 | 826457e2aafdb61ead8a0a44d8cf9088d310684b | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 5.52e-06 | 195 | 101 | 6 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | Adult-Immune-monocyte-D122|Adult / Lineage, Cell type, age group and donor | 5.69e-06 | 196 | 101 | 6 | 16b0acb6157534938ca83d4e909471e33a7d3c52 | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 5.86e-06 | 197 | 101 | 6 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | Transverse-(3)_ILC-(30)_ILC|Transverse / shred on region, Cell_type, and subtype | 6.39e-06 | 200 | 101 | 6 | 528520dc98775aca6cc7568fedf5906ea55e0bea | |
| ToppCell | Transverse-(3)_ILC|Transverse / shred on region, Cell_type, and subtype | 6.39e-06 | 200 | 101 | 6 | c1ad7cb012e1c8911e417f7d64ca662c4f5010e0 | |
| ToppCell | Transverse-ILC|Transverse / Region, Cell class and subclass | 6.39e-06 | 200 | 101 | 6 | eb04d6ad2270d3d9ac3d1fae1bb9bedc6fca38fe | |
| ToppCell | Transverse-ILC-ILC|Transverse / Region, Cell class and subclass | 6.39e-06 | 200 | 101 | 6 | 60ec185df2f1989bf8febf75b11c46a576829be3 | |
| ToppCell | 21-Trachea-Immune-Immune|Trachea / Age, Tissue, Lineage and Cell class | 1.37e-05 | 134 | 101 | 5 | 4f0465324cc5b443ebadb68aef63be79b74f6ff9 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.43e-05 | 151 | 101 | 5 | b698ddc74565d47892c09c3f16d78038da2dd5e7 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytotoxic_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.59e-05 | 153 | 101 | 5 | df2130689e53748e820a5835fa396fe82a5d2c7c | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 3.12e-05 | 159 | 101 | 5 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | severe_influenza-cDC|severe_influenza / disease group, cell group and cell class (v2) | 3.31e-05 | 161 | 101 | 5 | 7716315b8bda904b346cea47edc2c0b507a345c2 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Nefm_(dSPN)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.32e-05 | 80 | 101 | 4 | cb60461818f0900964d2a14c7f8462e7f37b3dff | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Nefm_(dSPN)|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.32e-05 | 80 | 101 | 4 | 27cc5ea77983fb0604545a0ff818eede8ba72b82 | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.94e-05 | 167 | 101 | 5 | 1e2fc1637769405a61f4c7e44945712a1888a299 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-05 | 168 | 101 | 5 | ce5e92a1df3acfa5cd8d5a134e4af231dc592a13 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-05 | 168 | 101 | 5 | 22c89d4eb44573f6301069ec7ca7cbd0dd958403 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.17e-05 | 169 | 101 | 5 | b2fdf9f842dc7c181bc951a8a6932c916ed835ef | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-05 | 169 | 101 | 5 | f38b52972a6c492ce2fd520a26bb3fc8db23bf85 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-05 | 169 | 101 | 5 | 5320da1d61806b53e0bd96bbdfdb8fd69246681b | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.17e-05 | 169 | 101 | 5 | 0ee74cc97a2db9cc16dc73424f74747afe13af90 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.17e-05 | 169 | 101 | 5 | 2322f03a115c662f808ebfc892192b7d38d48181 | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 170 | 101 | 5 | f8defd260dadd202692282e834ed7f38193eb553 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 171 | 101 | 5 | ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 171 | 101 | 5 | 97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3 | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.41e-05 | 171 | 101 | 5 | 714a0b0d0c9886fef64170cf53eb64f0d8a47280 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 5.06e-05 | 176 | 101 | 5 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | BAL-Mild-cDC_3|Mild / Compartment, Disease Groups and Clusters | 5.06e-05 | 176 | 101 | 5 | f9b0c3ced391e7ebe6b242d3f12ba14741f88d22 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 5.20e-05 | 177 | 101 | 5 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.93e-05 | 182 | 101 | 5 | 41b070085edba7a58b81c20aa4942d06f745acf8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.93e-05 | 182 | 101 | 5 | 5e9a67b2de0daa4fdc344b10a857d8a901ad810e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.93e-05 | 182 | 101 | 5 | b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-05 | 184 | 101 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-05 | 184 | 101 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-05 | 184 | 101 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-05 | 184 | 101 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LA-07._Pericyte|LA / Chamber and Cluster_Paper | 6.41e-05 | 185 | 101 | 5 | ba5baa4d7f097108622674de5b7f4fd279843d24 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-T_cells-NK_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.57e-05 | 186 | 101 | 5 | e083356f72995645f873ca0157d56bea5e942044 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.57e-05 | 186 | 101 | 5 | 4ae3c0fe8640a8d029875cf3f0f5ffbba38e85f8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 187 | 101 | 5 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 187 | 101 | 5 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 187 | 101 | 5 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | normal_Lung-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 6.74e-05 | 187 | 101 | 5 | a3592f056e1c2f82ba325fea2ecc4dd6c6347c81 | |
| ToppCell | normal_Lung-Myeloid_cells-pDCs|normal_Lung / Location, Cell class and cell subclass | 6.74e-05 | 187 | 101 | 5 | d36751372fd40a46441f07735c9c3c5dcb503f24 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-05 | 190 | 101 | 5 | 656483751e4bf137e4e4bfb2a03a478a8f7fcb63 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-NK-CD56bright_NK|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.27e-05 | 190 | 101 | 5 | c8031df82c3662ce4140c850277987f7210e9bcd | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 7.27e-05 | 190 | 101 | 5 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 7.27e-05 | 190 | 101 | 5 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.45e-05 | 191 | 101 | 5 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.45e-05 | 191 | 101 | 5 | d4f77c73311d1149466bbfe4adbd6a301946ec90 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 7.45e-05 | 191 | 101 | 5 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.64e-05 | 192 | 101 | 5 | df4741e7684f010445f0224a1fd61aaa4fae02b3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.64e-05 | 192 | 101 | 5 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 7.64e-05 | 192 | 101 | 5 | 4e689bca7a242f8482e25f273656e2caba8821c0 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 7.64e-05 | 192 | 101 | 5 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 7.82e-05 | 193 | 101 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 7.82e-05 | 193 | 101 | 5 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.82e-05 | 193 | 101 | 5 | 287e756d5fd3bd2931c168da24beaa0d02a350ae | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.02e-05 | 194 | 101 | 5 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.02e-05 | 194 | 101 | 5 | e237384b02be460d44eeada3026a5691c66f6fc1 | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 8.02e-05 | 194 | 101 | 5 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.02e-05 | 194 | 101 | 5 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.02e-05 | 194 | 101 | 5 | 0bc83ae79873a5e473e6e1e3111924cd003986a1 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.21e-05 | 195 | 101 | 5 | 81a28289eda1a8a1a31b7357106f64ac5000e172 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.21e-05 | 195 | 101 | 5 | 63e132fd6e4318299dd47bbe8ed3bf120efe46dd | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.21e-05 | 195 | 101 | 5 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 8.21e-05 | 195 | 101 | 5 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 8.21e-05 | 195 | 101 | 5 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.21e-05 | 195 | 101 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | facs-Heart-RA-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.21e-05 | 195 | 101 | 5 | 30c75761079fa1e1a3b84d23c88a222f459d5ce5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.41e-05 | 196 | 101 | 5 | a9157809122e6fc5783a291522f103bef30943e4 | |
| ToppCell | B_cells-Naive_B_cells_|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 8.62e-05 | 197 | 101 | 5 | fd5fdc5289d681d59ff22d72e4de6e74c6c7aac6 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.62e-05 | 197 | 101 | 5 | 48a8169a4d33c6a68d66bcd936861c75cb4b60ef | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.62e-05 | 197 | 101 | 5 | 1eb9ff8467118b943b5d443cb996168e1e1206b5 | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 8.62e-05 | 197 | 101 | 5 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.62e-05 | 197 | 101 | 5 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | distal-Hematologic-Myeloid_Dendritic_Type_2-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.83e-05 | 198 | 101 | 5 | 984b3753fabd5553f6f364f90a422b035e421535 | |
| ToppCell | Adult-Immune|Adult / Lineage, Cell type, age group and donor | 8.83e-05 | 198 | 101 | 5 | 9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-ILC|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.04e-05 | 199 | 101 | 5 | 3bac69726153e988a7f36613ee280c74d2fa7545 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 9.04e-05 | 199 | 101 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Caecum-ILC|Caecum / Region, Cell class and subclass | 9.25e-05 | 200 | 101 | 5 | a9a1f03b4f415da860fb52eaedb07f0743692c98 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.25e-05 | 200 | 101 | 5 | 881ab995c90d75fd987d6e8f1f926a4bfcc4235f | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 9.25e-05 | 200 | 101 | 5 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | Caecum-(3)_ILC-(30)_ILC|Caecum / shred on region, Cell_type, and subtype | 9.25e-05 | 200 | 101 | 5 | ccd323997613b65f0189c0c66d76fbf273e18c03 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 9.25e-05 | 200 | 101 | 5 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Caecum-ILC-ILC|Caecum / Region, Cell class and subclass | 9.25e-05 | 200 | 101 | 5 | 3ac18c3ef335cb83d6a826f6c7519a5e7804929d | |
| ToppCell | Caecum-(3)_ILC|Caecum / shred on region, Cell_type, and subtype | 9.25e-05 | 200 | 101 | 5 | 6857863b3200162c250123688af2cba681afcb35 | |
| ToppCell | COVID-19_Mild-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.83e-04 | 124 | 101 | 4 | 5ef9eb806fb2c8ee5aae0a75503d244b08ee10d4 | |
| Drug | Methotrimeprazine maleat salt [7104-38-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 2.28e-07 | 196 | 101 | 9 | 4723_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.53e-06 | 182 | 101 | 8 | 3887_DN | |
| Drug | Ganciclovir [82410-32-0]; Down 200; 15.6uM; PC3; HT_HG-U133A | 2.77e-06 | 197 | 101 | 8 | 6289_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.58e-05 | 180 | 101 | 7 | 6886_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.82e-05 | 184 | 101 | 7 | 2321_DN | |
| Drug | pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A | 2.24e-05 | 190 | 101 | 7 | 7528_DN | |
| Drug | Clenbuterol hydrochloride [21898-19-1]; Down 200; 12.8uM; PC3; HT_HG-U133A | 2.48e-05 | 193 | 101 | 7 | 4671_DN | |
| Drug | Amphotericin B [1397-89-3]; Down 200; 4.4uM; HL60; HT_HG-U133A | 2.73e-05 | 196 | 101 | 7 | 2441_DN | |
| Drug | Carbimazole [22232-54-8]; Down 200; 21.4uM; HL60; HT_HG-U133A | 2.73e-05 | 196 | 101 | 7 | 2437_DN | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; PC3; HT_HG-U133A | 2.73e-05 | 196 | 101 | 7 | 2101_UP | |
| Drug | Sulpiride [15676-16-1]; Down 200; 11.8uM; HL60; HG-U133A | 2.73e-05 | 196 | 101 | 7 | 1967_DN | |
| Drug | Thyroxine (L) [51-48-9]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 2.82e-05 | 197 | 101 | 7 | 4150_UP | |
| Drug | Piromidic acid [19562-30-2]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 2.82e-05 | 197 | 101 | 7 | 3335_DN | |
| Drug | Aspartic acid, N-acetyl (R,S) [997-55-7]; Down 200; 22.8uM; HL60; HT_HG-U133A | 2.92e-05 | 198 | 101 | 7 | 1329_DN | |
| Drug | D-cycloserine [68-41-7]; Up 200; 39.2uM; PC3; HT_HG-U133A | 3.01e-05 | 199 | 101 | 7 | 7134_UP | |
| Drug | Procaine hydrochloride [51-05-8]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 3.01e-05 | 199 | 101 | 7 | 5430_UP | |
| Drug | Saquinavir mesylate [149845-06-7]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 3.11e-05 | 200 | 101 | 7 | 3549_UP | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.19e-04 | 172 | 101 | 6 | 7073_DN | |
| Drug | SAHA; Down 200; 10uM; HL60; HT_HG-U133A | 1.31e-04 | 175 | 101 | 6 | 1161_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.35e-04 | 176 | 101 | 6 | 6546_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 1.53e-04 | 180 | 101 | 6 | 4541_DN | |
| Drug | tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA | 1.77e-04 | 185 | 101 | 6 | 1114_DN | |
| Drug | Securinine [5610-40-2]; Down 200; 18.4uM; HL60; HT_HG-U133A | 1.88e-04 | 187 | 101 | 6 | 2729_DN | |
| Drug | AC1O4QHN | 1.93e-04 | 5 | 101 | 2 | CID006398424 | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; PC3; HT_HG-U133A | 2.17e-04 | 192 | 101 | 6 | 5058_DN | |
| Drug | Cinoxacin [28657-80-9]; Down 200; 15.2uM; HL60; HT_HG-U133A | 2.17e-04 | 192 | 101 | 6 | 2722_DN | |
| Drug | Bisacodyl [603-50-9]; Down 200; 11uM; PC3; HT_HG-U133A | 2.23e-04 | 193 | 101 | 6 | 4616_DN | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 2.23e-04 | 193 | 101 | 6 | 2283_UP | |
| Drug | Phenazopyridine hydrochloride [136-40-3]; Down 200; 16uM; PC3; HT_HG-U133A | 2.23e-04 | 193 | 101 | 6 | 5758_DN | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A | 2.29e-04 | 194 | 101 | 6 | 1670_DN | |
| Drug | Tacrine hydrochloride hydrate [1684-40-8]; Up 200; 15.8uM; HL60; HT_HG-U133A | 2.29e-04 | 194 | 101 | 6 | 1278_UP | |
| Drug | Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; PC3; HT_HG-U133A | 2.29e-04 | 194 | 101 | 6 | 4262_DN | |
| Drug | radicicol; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.29e-04 | 194 | 101 | 6 | 5952_DN | |
| Drug | Cefoperazone dihydrate; Down 200; 5.8uM; MCF7; HT_HG-U133A | 2.36e-04 | 195 | 101 | 6 | 5424_DN | |
| Drug | Cefepime hydrochloride [123171-59-5]; Up 200; 7.4uM; HL60; HT_HG-U133A | 2.36e-04 | 195 | 101 | 6 | 6159_UP | |
| Drug | wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A | 2.36e-04 | 195 | 101 | 6 | 5240_UP | |
| Drug | Cholecalciferol [67-97-0]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 2.36e-04 | 195 | 101 | 6 | 3298_UP | |
| Drug | Carbimazole [22232-54-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A | 2.36e-04 | 195 | 101 | 6 | 5399_DN | |
| Drug | Risperidone [106266-06-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 2.36e-04 | 195 | 101 | 6 | 3508_DN | |
| Drug | Ethionamide [536-33-4]; Down 200; 24uM; MCF7; HT_HG-U133A | 2.36e-04 | 195 | 101 | 6 | 4418_DN | |
| Drug | Oxethazaine [126-27-2]; Up 200; 8.6uM; PC3; HG-U133A | 2.36e-04 | 195 | 101 | 6 | 1903_UP | |
| Drug | Deoxycorticosterone [64-85-7]; Up 200; 12.2uM; HL60; HT_HG-U133A | 2.36e-04 | 195 | 101 | 6 | 3099_UP | |
| Drug | Amphotericin B [1397-89-3]; Up 200; 4.4uM; PC3; HT_HG-U133A | 2.36e-04 | 195 | 101 | 6 | 6303_UP | |
| Drug | Karakoline [39089-30-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.36e-04 | 195 | 101 | 6 | 4763_UP | |
| Drug | Azapropazone [13539-59-8]; Down 200; 13.4uM; PC3; HT_HG-U133A | 2.42e-04 | 196 | 101 | 6 | 7277_DN | |
| Drug | Sulfisoxazole [127-69-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 2.42e-04 | 196 | 101 | 6 | 5622_UP | |
| Drug | Carbenoxolone disodium salt [7421-40-1]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 2.42e-04 | 196 | 101 | 6 | 3353_DN | |
| Drug | Nomifensine maleate [32795-47-4]; Up 200; 11.2uM; PC3; HT_HG-U133A | 2.42e-04 | 196 | 101 | 6 | 5863_UP | |
| Drug | Clorgyline hydrochloride [17780-75-5]; Down 200; 13uM; MCF7; HT_HG-U133A | 2.42e-04 | 196 | 101 | 6 | 5005_DN | |
| Drug | Papaverine hydrochloride [61-25-6]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 2.42e-04 | 196 | 101 | 6 | 6245_DN | |
| Drug | rosiglitazone; Down 200; 10uM; HL60; HT_HG-U133A | 2.42e-04 | 196 | 101 | 6 | 1174_DN | |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; PC3; HT_HG-U133A | 2.42e-04 | 196 | 101 | 6 | 3724_DN | |
| Drug | Cefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 2.42e-04 | 196 | 101 | 6 | 4718_DN | |
| Drug | Indapamide [26807-65-8]; Down 200; 10.6uM; HL60; HT_HG-U133A | 2.42e-04 | 196 | 101 | 6 | 2361_DN | |
| Drug | Thyroxine (L) [51-48-9]; Down 200; 5.2uM; HL60; HT_HG-U133A | 2.42e-04 | 196 | 101 | 6 | 1312_DN | |
| Drug | CGX 0596987; Down 200; 20uM; MCF7; HT_HG-U133A | 2.49e-04 | 197 | 101 | 6 | 6412_DN | |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; PC3; HT_HG-U133A | 2.49e-04 | 197 | 101 | 6 | 1224_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | 2.49e-04 | 197 | 101 | 6 | 2702_DN | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 2.49e-04 | 197 | 101 | 6 | 3723_DN | |
| Drug | Aminocaproic acid [60-32-2]; Down 200; 30.4uM; HL60; HT_HG-U133A | 2.49e-04 | 197 | 101 | 6 | 3122_DN | |
| Drug | Mefexamide hydrochloride [3413-64-7]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 2.49e-04 | 197 | 101 | 6 | 7478_UP | |
| Drug | Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 2.49e-04 | 197 | 101 | 6 | 4730_UP | |
| Drug | Guanadrel sulfate [22195-34-2]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 2.49e-04 | 197 | 101 | 6 | 4720_DN | |
| Drug | 0173570-0000 [211245-44-2]; Up 200; 1uM; PC3; HT_HG-U133A | 2.56e-04 | 198 | 101 | 6 | 7391_UP | |
| Drug | Sulfanilamide [63-74-1]; Down 200; 23.2uM; MCF7; HT_HG-U133A | 2.56e-04 | 198 | 101 | 6 | 3449_DN | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; MCF7; HT_HG-U133A | 2.56e-04 | 198 | 101 | 6 | 4791_DN | |
| Drug | Budesonide [51333-22-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 2.56e-04 | 198 | 101 | 6 | 5431_DN | |
| Drug | Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; PC3; HT_HG-U133A | 2.56e-04 | 198 | 101 | 6 | 7366_DN | |
| Drug | Myricetin [529-44-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 2.56e-04 | 198 | 101 | 6 | 3270_UP | |
| Drug | (-)-MK 801 hydrogen maleate [77086-19-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.56e-04 | 198 | 101 | 6 | 6657_DN | |
| Drug | Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 2.56e-04 | 198 | 101 | 6 | 1479_DN | |
| Drug | Azacyclonol [115-46-8]; Down 200; 15uM; MCF7; HT_HG-U133A | 2.56e-04 | 198 | 101 | 6 | 5398_DN | |
| Drug | Tiabendazole [148-79-8]; Down 200; 19.8uM; PC3; HT_HG-U133A | 2.56e-04 | 198 | 101 | 6 | 4579_DN | |
| Drug | Tetrahydroalstonine [6474-90-4]; Down 200; 11.4uM; HL60; HG-U133A | 2.63e-04 | 199 | 101 | 6 | 1756_DN | |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Down 200; 12.4uM; HL60; HT_HG-U133A | 2.63e-04 | 199 | 101 | 6 | 2404_DN | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; HL60; HT_HG-U133A | 2.63e-04 | 199 | 101 | 6 | 2683_DN | |
| Drug | Natamycin [7681-93-8]; Down 200; 6uM; PC3; HT_HG-U133A | 2.63e-04 | 199 | 101 | 6 | 5809_DN | |
| Drug | Metrizamide [31112-62-6]; Down 200; 5uM; HL60; HT_HG-U133A | 2.63e-04 | 199 | 101 | 6 | 1318_DN | |
| Drug | beta- Belladonnine dichloroethylate [191355-47-2]; Down 200; 6uM; MCF7; HT_HG-U133A | 2.63e-04 | 199 | 101 | 6 | 2819_DN | |
| Drug | Cyproterone acetate [427-51-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.63e-04 | 199 | 101 | 6 | 6806_DN | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; PC3; HT_HG-U133A | 2.63e-04 | 199 | 101 | 6 | 5949_DN | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; PC3; HT_HG-U133A | 2.63e-04 | 199 | 101 | 6 | 7384_UP | |
| Drug | Ethoxyquin [91-53-2]; Up 200; 18.4uM; PC3; HT_HG-U133A | 2.63e-04 | 199 | 101 | 6 | 3764_UP | |
| Drug | Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; PC3; HT_HG-U133A | 2.63e-04 | 199 | 101 | 6 | 6624_DN | |
| Drug | Epirizole [18694-40-1]; Down 200; 17uM; MCF7; HT_HG-U133A | 2.70e-04 | 200 | 101 | 6 | 1681_DN | |
| Drug | PF-01378883-00 [351320-41-7]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.70e-04 | 200 | 101 | 6 | 6405_DN | |
| Drug | Suramin sodium salt; Up 200; 10uM; PC3; HT_HG-U133A | 2.70e-04 | 200 | 101 | 6 | 7501_UP | |
| Drug | S(+)-Terguride [37686-84-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.70e-04 | 200 | 101 | 6 | 5400_UP | |
| Disease | breast cancer (is_marker_for) | 3.33e-06 | 185 | 100 | 7 | DOID:1612 (is_marker_for) | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 2.48e-05 | 17 | 100 | 3 | DOID:0060307 (is_implicated_in) | |
| Disease | Kabuki syndrome (implicated_via_orthology) | 3.40e-05 | 3 | 100 | 2 | DOID:0060473 (implicated_via_orthology) | |
| Disease | platelet component distribution width | DENND2A CD2AP SIN3A ASAP1 TXK DOCK5 NCOR2 SETD2 RBM6 FYB1 PRRC2A | 5.13e-05 | 755 | 100 | 11 | EFO_0007984 |
| Disease | Intellectual Disability | 1.44e-04 | 447 | 100 | 8 | C3714756 | |
| Disease | Embryonal Rhabdomyosarcoma | 3.14e-04 | 8 | 100 | 2 | C0206656 | |
| Disease | Adenoid Cystic Carcinoma | 3.79e-04 | 100 | 100 | 4 | C0010606 | |
| Disease | alopecia areata (is_marker_for) | 5.03e-04 | 10 | 100 | 2 | DOID:986 (is_marker_for) | |
| Disease | serum alanine aminotransferase measurement | DLG5 PCLO CD2AP ARID1A PRAG1 C4orf17 ZNF827 FAM222B RBM6 SOS2 | 7.40e-04 | 869 | 100 | 10 | EFO_0004735 |
| Disease | colorectal cancer (is_implicated_in) | 7.79e-04 | 121 | 100 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 7.82e-04 | 53 | 100 | 3 | C1961099 | |
| Disease | urate measurement | SIN3A ARID1A REXO1 ASAP2 SH2D4A CEP89 ZNF827 RBM6 KDM4B SOS2 | 9.26e-04 | 895 | 100 | 10 | EFO_0004531 |
| Disease | malignant pleural mesothelioma (is_marker_for) | 1.01e-03 | 14 | 100 | 2 | DOID:7474 (is_marker_for) | |
| Disease | Replication Error Phenotype | 1.16e-03 | 15 | 100 | 2 | C1721098 | |
| Disease | Microsatellite Instability | 1.16e-03 | 15 | 100 | 2 | C0920269 | |
| Disease | testosterone measurement | FAM184A FGFRL1 SIN3A ARID1A CHAMP1 REXO1 OPHN1 DOCK5 NCOR2 KCNQ5 UTRN SOS2 | 1.27e-03 | 1275 | 100 | 12 | EFO_0004908 |
| Disease | T-Cell Lymphoma | 1.32e-03 | 16 | 100 | 2 | C0079772 | |
| Disease | stomach cancer (is_marker_for) | 1.41e-03 | 142 | 100 | 4 | DOID:10534 (is_marker_for) | |
| Disease | Sclerocystic Ovaries | 1.48e-03 | 144 | 100 | 4 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 1.48e-03 | 144 | 100 | 4 | C0032460 | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.68e-03 | 69 | 100 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | Congenital hernia of foramen of Morgagni | 1.87e-03 | 19 | 100 | 2 | C0265699 | |
| Disease | Congenital hernia of foramen of Bochdalek | 1.87e-03 | 19 | 100 | 2 | C0265700 | |
| Disease | stomach cancer (is_implicated_in) | 1.90e-03 | 72 | 100 | 3 | DOID:10534 (is_implicated_in) | |
| Disease | prostate cancer (is_marker_for) | 1.99e-03 | 156 | 100 | 4 | DOID:10283 (is_marker_for) | |
| Disease | colorectal cancer (is_marker_for) | 2.04e-03 | 157 | 100 | 4 | DOID:9256 (is_marker_for) | |
| Disease | Congenital diaphragmatic hernia | 2.29e-03 | 21 | 100 | 2 | C0235833 | |
| Disease | Granulomatous Slack Skin | 2.51e-03 | 22 | 100 | 2 | C0376407 | |
| Disease | Lymphoma, T-Cell, Cutaneous | 2.75e-03 | 23 | 100 | 2 | C0079773 | |
| Disease | Noonan Syndrome | 2.99e-03 | 24 | 100 | 2 | C0028326 | |
| Disease | Autism Spectrum Disorders | 3.05e-03 | 85 | 100 | 3 | C1510586 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RPPAPPLQPSLDIKP | 21 | Q9H6B1 | |
| GSLTPQPTQPPPKPK | 816 | Q96JP9 | |
| APQAQPPKPVPKPRT | 86 | Q8WWN8 | |
| PEPQPVTPAPPPAKK | 636 | P49711 | |
| DVAKKPPPAPQQPPP | 31 | Q07065 | |
| SNPKLPPPKPLPGTL | 706 | O14672 | |
| PPPKIPKIETTHPPL | 351 | O75909 | |
| DNPRPQKKIPIPPLP | 71 | Q7L190 | |
| KLAQPPPPQPPSLNK | 781 | Q9ULD4 | |
| KPSIQPKPLLLPAAP | 176 | P18850 | |
| PPPPAKAPAPKPELI | 341 | Q9Y5K6 | |
| PKQVIKPTFAPPVPP | 771 | P78325 | |
| PQPVPPKGPKTFLSP | 1101 | Q8NB25 | |
| SNGKNPPTLKPVPPP | 1011 | P58397 | |
| PPVPPLPKVTPTKEL | 301 | P49418 | |
| APLPPQAPPKPLVTI | 771 | Q70E73 | |
| ETLPPPAAPPKPGKL | 1016 | Q70E73 | |
| SIEPPKPPQHPKLPI | 626 | O60890 | |
| PTVPLKPPPPLTLGK | 356 | Q96CB8 | |
| KLKPPPSSLPPPTPI | 486 | Q8WYB5 | |
| PPPPPPSELKKAEQQ | 16 | O14497 | |
| LGVKPDLPPPPSKAP | 1791 | P51610 | |
| KLLKREGTPPPPPPS | 1376 | Q9Y618 | |
| PAKPPVSPKPVLTQP | 1221 | Q8WXD9 | |
| LSFKPPEPPKPPGSL | 346 | Q15759 | |
| DPLKVPPPLPDPSSI | 826 | Q66K74 | |
| KKAQTAPPLQPPPPP | 96 | Q96MG2 | |
| PQPPSRLPQKKPAPG | 881 | O43150 | |
| KPAAPTTLQIPPPLP | 741 | Q9NR82 | |
| SPYPPLPKDKLNPPT | 926 | O15550 | |
| KPPFLATPPLPPLQS | 351 | Q9H165 | |
| IIKPPLQQQPPKPIP | 206 | Q9Y6V0 | |
| PLPPPTSPKPTILPK | 2426 | Q9Y6V0 | |
| SKPPIAPKPVIPQLP | 2506 | Q9Y6V0 | |
| AQKKPCTPAPAPPLP | 401 | Q8N441 | |
| NPEPLPPPLPKKILT | 51 | Q6ZS72 | |
| KPPLPACEPSLPSPK | 606 | P35663 | |
| HLKPPLEKPTPSPPV | 421 | Q8WU58 | |
| TPKQKPLPPLFTLGP | 341 | O15117 | |
| PPPKPNRPPNVDLTK | 356 | O15117 | |
| PQPSKRAGPLTPPKP | 1001 | Q8TDM6 | |
| KKSFGLLPPQLPPPP | 456 | O94953 | |
| KEEAKLPPPPLTPPA | 396 | Q9UMN6 | |
| PPLKTSPQLRVPPPT | 1931 | Q9UMN6 | |
| EKTLLEIPPPKPPAP | 361 | Q8WXI9 | |
| PLKPPPPPRQLSVKD | 141 | Q86UU5 | |
| IKDEPPPLSPAPLTP | 3911 | Q7Z6Z7 | |
| ENVPKPPLLPPKRPL | 161 | Q8IZ21 | |
| RPPEPLSSKPPLPRK | 751 | Q6NV74 | |
| IPPKATPEPAIPPKA | 641 | Q5T0Z8 | |
| EKEKKLPPPPPQAPP | 146 | O60341 | |
| IAATPVPPPPPPKSK | 1811 | Q9H7D0 | |
| VPPPRSTKPLLAPKP | 411 | Q99704 | |
| PTLPQKPLPNKPSPT | 2981 | Q9H799 | |
| KEKRNLPPLPSLPPP | 291 | Q9ULE3 | |
| PERDPSPVPKPSPKI | 201 | A8K855 | |
| NPPPIPPKKPGLSQT | 541 | Q8WZ74 | |
| PPKKPGLSQTPSPPH | 546 | Q8WZ74 | |
| PKPTPLTPLEPQKPG | 146 | Q96JM3 | |
| KPPLCEKPPPSPDIT | 211 | Q96ST8 | |
| PPTVKSPPTVKLPPN | 246 | Q53FE4 | |
| KKPPPSPIPLTFDEP | 1351 | Q8TDW7 | |
| KLSRLKPAPPPPPAA | 891 | P00519 | |
| PGDLPPKPTELAPKP | 936 | Q9ULH1 | |
| ELPPKPQLGDLPPKP | 961 | Q9ULH1 | |
| LPPKPQLSDLPPKPQ | 971 | Q9ULH1 | |
| KVVPLRPPPPPKSQA | 31 | Q9UHN6 | |
| SPPLKPPISPPKTPV | 6 | Q5BKX5 | |
| FIPKGRPPKLTQPPP | 451 | Q96PD2 | |
| PDPEKLPVPPAPPSK | 101 | Q9NYF3 | |
| EPPPKPVFPPTAPKN | 1106 | Q08AD1 | |
| EDTPPPLPPKPKFRS | 391 | Q92918 | |
| PPSRELDKPPLLPPK | 461 | Q92918 | |
| KKSPPLPPATPGPHL | 251 | Q96JB3 | |
| PPKRLKASPPPSPAP | 566 | Q8N1G1 | |
| LPPPPPPKKRQIHVD | 671 | P46939 | |
| PTSPYPPLPKDKLNP | 871 | O14607 | |
| PPLPKDKLNPPTPSI | 876 | O14607 | |
| PLPPTVKKEESPPPP | 881 | P78332 | |
| LAQALLVKQPPPPPP | 1206 | Q9HCJ0 | |
| EEPLIPPPLPPRKKF | 1141 | Q07890 | |
| PPANPPVPVLQSKPL | 186 | Q5HYK7 | |
| KVPPERPPPPKLSAT | 341 | Q5HYK7 | |
| QKDPAQPLEPKRPPP | 1096 | O43426 | |
| PPLSDFPKKPPQPEL | 276 | Q96QH2 | |
| PPPTKVEELPPKPLE | 956 | P48634 | |
| SLAPKKPPTGPLPPS | 1191 | P48634 | |
| KLLRPLSPVTPPPPN | 846 | Q9C0A6 | |
| KPGLPPPASKPLRPT | 1581 | Q7Z333 | |
| PAPQPPPAKVSKPSQ | 241 | Q96ST3 | |
| KPLLQAPFLPPKAPP | 226 | O94844 | |
| APFLPPKAPPPVIKI | 231 | O94844 | |
| PKAPPPVIKIPECPS | 236 | O94844 | |
| LKKIPIPETPPQTPP | 281 | Q969H4 | |
| TGVLPPPTLPKPKLP | 2241 | A4UGR9 | |
| PPPKENKPPPVLITL | 186 | Q8IZ63 | |
| LQRPPPTLPPSKPKP | 171 | Q8NHH1 | |
| PPLPKIQPLEPDSPT | 991 | Q9ULJ3 | |
| KPEKPPEPDIPLLPR | 366 | Q8N2C7 | |
| SPPPALPPKKRQSAP | 281 | Q13905 | |
| PPLKPPKGTRQPNKP | 326 | O94991 | |
| QVRPKPAPSPKTEPP | 641 | A1X283 | |
| QPPPQEPCIPKTKEP | 26 | P35321 | |
| QPPPQEPCIPKTKEP | 26 | P22528 | |
| QKPERPPLPPKPQFL | 281 | Q9H788 | |
| PDAAPKPPIPIQSKP | 486 | P78364 | |
| KPPIPIQSKPPVAPI | 491 | P78364 | |
| NLPDLPPALVPSPPK | 61 | Q9BWH6 | |
| KHKPPLPCPLPPLQN | 1931 | Q9UGU0 | |
| PPFLELLPSPAPKPV | 546 | Q6ZUG5 | |
| FSPPPPPPKSRHLLK | 711 | Q86YV5 | |
| PSGPQQPPPLPQKKI | 806 | Q86YV5 | |
| PLEKFPLKPGVPLPS | 436 | Q00722 | |
| LDLPPPSPPKPKTIV | 2376 | Q9BYW2 | |
| KSSLLPEDPLPPPPS | 306 | Q17R98 | |
| PSKRKPLPPLPPSEV | 66 | P42681 | |
| DLKPGQSPAIPPPLP | 281 | Q13061 | |
| PAPPQKTPPPSQKAP | 496 | Q8N5Q1 | |
| PLAPSPVPTLPPKQQ | 1801 | E9PAV3 |